Skin disorder
MONDO:0005093Any deviation from the normal structure or function of the skin or subcutaneous tissue that is manifested by a characteristic set of symptoms and signs.
Also known as: cutaneous disorder, disease of zone of skin, disease or disorder of zone of skin, disorder of skin, disorder of zone of skin, skin diseases and manifestations, skin disorder, zone of skin disease
3761 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsSub-types
Broader categories
Showing the 400 most recently updated of 1068 trials in this tab.
-
Engineered immune cells take aim at Hard-to-Treat leukemias
⭐️ CURE ⭐️ CompletedThis trial is testing a new type of immune cell therapy called CD123 CAR-NK cells in people with relapsed or refractory acute myeloid leukemia (AML) or blastic plasmacytoid dendritic cell neoplasm (BPDCN). The cells are designed to find and attack cancer cells that carry a protei…
Phase: PHASE1, PHASE2 • Sponsor: Chongqing Precision Biotech Co., Ltd • Aim: ⭐️ CURE ⭐️
Last updated Aug 07, 2026 00:00 UTC
-
New ear oil shows promise against fungal infections
⭐️ CURE ⭐️ CompletedThis study tested whether miconazole oil can cure fungal ear infections (otomycosis). 112 adults with ear fungus received either the active oil or a placebo for 14 days. Neither patients nor doctors knew who got the real treatment. After two weeks, doctors checked if the infectio…
Phase: PHASE3 • Sponsor: Hill Dermaceuticals, Inc. • Aim: ⭐️ CURE ⭐️
Last updated Jun 27, 2026 12:31 UTC
-
New mRNA shingles shot shows promise in early trial
⭐️ VACCINE ⭐️ CompletedThis early-stage study tested a new mRNA vaccine called IN001 for preventing shingles in 150 healthy adults aged 50 to 69. The main goals were to check the vaccine's safety, side effects, and how well it triggers the immune system. Researchers gave different doses to find the bes…
Phase: PHASE1 • Sponsor: Shenzhen Shenxin Biotechnology Co., Ltd • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:02 UTC
-
New vaccine aims to shield kids from hand, foot, and mouth disease
⭐️ VACCINE ⭐️ CompletedThis study tested a new vaccine designed to protect against hand, foot, and mouth disease and herpangina, which are common viral infections in children. The trial involved 552 healthy adults and children aged 6 months to 12 years. Participants received either a low, medium, or hi…
Phase: PHASE1, PHASE2 • Sponsor: Sinovac Biotech Co., Ltd • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 09:10 UTC
-
Experimental drug shows promise for rare immune disorders
Disease control CompletedThis early-phase study tested the safety of rituximab, a drug that targets faulty white blood cells, in 7 adults with rare immune diseases like pulmonary alveolar proteinosis and severe candidiasis. Participants received several doses over 6 months and were monitored for 18 month…
Phase: PHASE1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Aug 18, 2026 05:00 UTC
-
Could a stem cell drug tame rare immune disease?
Disease control CompletedThis early-phase study tests whether Mozobil, a drug already used to boost stem cells for transplants, can safely raise white blood cell counts in people with WHIMS. WHIMS is a rare genetic condition that traps infection-fighting cells in the bone marrow, leading to frequent infe…
Phase: PHASE1, PHASE2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Aug 18, 2026 05:00 UTC
-
New study tracks how well eczema drug works in real life for 1,000 patients in china
Disease control CompletedThis study will follow about 1,000 adolescents and adults in China who are prescribed upadacitinib for moderate to severe atopic dermatitis (eczema). Researchers will track how patients use the medication, any dose changes, and how well they stick to their treatment over 12 month…
Sponsor: AbbVie • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
Can a drug duo outsmart resistant T-Cell lymphoma?
Disease control CompletedThis phase II trial is testing whether combining brentuximab vedotin, a targeted antibody-drug conjugate, with lenalidomide, a chemotherapy drug, can shrink tumors in people with T-cell lymphoma that has relapsed or not responded to earlier treatment. The study enrolls adults wit…
Phase: PHASE2 • Sponsor: John Reneau • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
New drug shot shows promise for tough eczema in large trial
Disease control CompletedThis study tested a new drug called amlitelimab, given as a shot under the skin, for people aged 12 and older with moderate-to-severe atopic dermatitis (eczema) that wasn't controlled by creams. The trial included 643 participants and compared amlitelimab to a placebo, while ever…
Phase: PHASE3 • Sponsor: Sanofi • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
New eczema drug shows promise in Late-Stage trial
Disease control CompletedThis Phase 3 study tests amlitelimab, an injected drug, in 589 people aged 12 and older with moderate-to-severe atopic dermatitis (eczema) that hasn't responded well to topical treatments. The goal is to see if amlitelimab can clear or nearly clear the skin and reduce eczema seve…
Phase: PHASE3 • Sponsor: Sanofi • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
Light-Activated gel shows promise for psoriasis in early trial
Disease control CompletedThis study tested a gel called SGX302, which is activated by visible light, on 15 people with mild-to-moderate plaque psoriasis. The goal was to see if it could clear or nearly clear skin lesions over 18 weeks. The treatment is applied to the skin and then exposed to light, aimin…
Phase: PHASE2 • Sponsor: Soligenix • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
New drug cocktail shows promise for Hard-to-Treat blood cancers
Disease control CompletedThis early-phase trial tested a combination of four drugs (romidepsin, CC-486, dexamethasone, and lenalidomide) in 26 adults with T-cell cancers that had returned or stopped responding to prior treatments. The main goal was to find a safe dose and check for side effects. While th…
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
Can your own fat cells help restore skin color in vitiligo?
Disease control CompletedThis trial tests whether injecting a specially processed form of a patient's own fat tissue, called nanofat, can improve repigmentation in stable vitiligo when combined with standard narrowband UVB light therapy. In each of 20 adults, one vitiligo patch receives nanofat plus ligh…
Phase: NA • Sponsor: Benha University • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
New gel could speed healing after skin cancer surgery on face and neck
Disease control CompletedThis study tests whether a gel containing a human growth factor (rhPDGF-BB) can help wounds heal faster after skin cancer removal on the head or neck. About 40 adults whose surgical wounds are too large to stitch closed will receive either the gel or a placebo. The goal is to see…
Phase: PHASE2 • Sponsor: Vanderbilt University Medical Center • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
New shot could ease painful skin condition
Disease control CompletedThis study tested a drug called sonelokimab, given as a shot under the skin, in 422 adults with moderate to severe hidradenitis suppurativa (a painful skin condition causing boils and abscesses). Participants were randomly assigned to receive either the drug or a placebo for up t…
Phase: PHASE3 • Sponsor: MoonLake Immunotherapeutics AG • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
Iron pills may give female footballers a performance edge
Disease control CompletedThis pilot study looks at whether a daily low-dose iron supplement (27 mg for three months) can improve iron status, gut health, and endurance in young female elite football players. Researchers will track diet, blood markers like hemoglobin and ferritin, gut leakage indicators, …
Phase: NA • Sponsor: Norwegian University of Life Sciences • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Can a common steroid gel quiet oral lichen planus by altering MicroRNAs?
Disease control CompletedThis trial investigates whether a topical clobetasol gel can change the levels of microRNAs in the gum fluid of people with oral lichen planus, a chronic inflammatory condition. Participants will apply either the active gel or a placebo to their lesions, and researchers will comp…
Phase: NA • Sponsor: University of Catania • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Can a cancer drug slow down advanced melanoma? small trial hopes to find out
Disease control CompletedThis phase 2 trial is testing the drug ibrutinib in 18 people with stage IV melanoma that has not responded to previous treatments. Ibrutinib works by blocking certain enzymes that help cancer cells grow. The study aims to see if the drug can shrink tumors and how long it keeps t…
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
New psoriasis pill shows promise in major trial
Disease control CompletedThis study tested a new daily medicine called ESK-001 in 862 adults with moderate to severe plaque psoriasis. The goal was to see if it reduces psoriasis severity and is safe, comparing it to a placebo and an existing drug (apremilast). Participants took the medicine for 24 weeks…
Phase: PHASE3 • Sponsor: Alumis Inc • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
New psoriasis pill shows promise in large trial
Disease control CompletedThis study tested whether a new daily pill, ESK-001, can safely reduce psoriasis severity in adults with moderate to severe plaque psoriasis. Over 900 participants took either ESK-001, a placebo (dummy pill), or an approved psoriasis drug (apremilast) for 24 weeks. Researchers me…
Phase: PHASE3 • Sponsor: Alumis Inc • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
Can a Once-Daily cream tame psoriasis in toddlers?
Disease control CompletedThis trial tests whether a once-daily application of ARQ-151 cream 0.3% is safe and well-tolerated in children aged 2 to 5 with plaque psoriasis. Over four weeks, researchers measure how much of the drug enters the bloodstream and watch for any side effects or skin reactions. The…
Phase: PHASE2 • Sponsor: Arcutis Biotherapeutics, Inc. • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
Can a skin cream replace a diabetes drug for dark patches?
Disease control CompletedThis trial tests three ways to treat acanthosis nigricans, a skin condition causing dark, thick patches often linked to insulin resistance and obesity. About 54 people with the condition will receive either oral metformin, a topical metformin cream, or a glycolic acid chemical pe…
Phase: NA • Sponsor: Tanta University • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
New shot could tame stubborn hives when other treatments fail
Disease control CompletedThis trial tests a drug called briquilimab for adults with chronic spontaneous urticaria (CSU) — long-lasting hives and itching that don't get better with standard antihistamines or omalizumab. The study has three parts, with some participants getting the drug and others a placeb…
Phase: PHASE1, PHASE2 • Sponsor: Jasper Therapeutics, Inc. • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
Can a new drug tame advanced solid tumors?
Disease control CompletedThis early-stage trial is testing an experimental drug called AEB1102 in people with advanced solid tumors that have not responded to standard treatments or for which no standard treatment exists. The main goal is to find the highest dose that is safe and to understand the drug's…
Phase: PHASE1 • Sponsor: Immedica Pharma AB • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
Lab-Grown skin could revolutionize burn treatment
Disease control CompletedThis study tests a new lab-grown skin substitute (EHSG-KF) for treating deep burns in adults and teens. It compares the substitute to standard skin grafts to see if it covers wounds better and is safer. The goal is to improve healing and reduce the need for large skin donations f…
Phase: PHASE2 • Sponsor: CUTISS AG • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
New eczema drug shows promise in major trial
Disease control CompletedThis study tested a new medicine called rocatinlimab, given as an injection, for adults with moderate-to-severe eczema that wasn't well controlled with standard creams. About 746 participants received either the study drug or a placebo, along with topical treatments. The goal was…
Phase: PHASE3 • Sponsor: Amgen • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
Can a new pill silence the itch of chronic hives?
Disease control CompletedThis trial is testing whether an experimental oral drug called rilzabrutinib can reduce the itching and hives in adults with chronic spontaneous urticaria (CSU) — a condition where hives appear without a clear trigger — even when standard antihistamines haven't helped. Participan…
Phase: PHASE2 • Sponsor: Sanofi • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
New shot offers hope for stubborn hand eczema
Disease control CompletedThis study tested a drug called tralokinumab for people with moderate-to-severe atopic hand eczema that hasn't improved with standard treatments. 235 adults received either the drug or a placebo every two weeks for 16 weeks, then everyone got the drug for another 16 weeks. The go…
Phase: PHASE3 • Sponsor: LEO Pharma • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
New pill could help kids with severe eczema
Disease control CompletedThis study tests whether baricitinib, an oral anti-inflammatory drug, is safe and effective for children aged 2 to 17 with moderate to severe atopic dermatitis (eczema). About 516 participants will receive either baricitinib or a placebo, along with standard topical steroids. The…
Phase: PHASE3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
Can a new biologic clear stubborn psoriasis?
Disease control CompletedThis Phase III trial is testing an investigational biologic called LZM012 in adults with moderate-to-severe plaque psoriasis. The drug targets two inflammatory proteins, IL-17A and IL-17F, to potentially reduce skin symptoms. Participants will receive LZM012 injections, and resea…
Phase: PHASE3 • Sponsor: Livzon Pharmaceutical Group Inc. • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
Can ozonated oil soothe eczema in kids?
Disease control CompletedThis trial tests whether a topical ozonated vegetable oil can reduce the severity of mild-to-moderate atopic dermatitis (eczema) in children aged 1 month to 6 years. Over 14 days, researchers compare the oil against a placebo, measuring changes in a standard eczema severity score…
Phase: NA • Sponsor: Laboratorios Ozoaqua • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
New hope for kids with severe psoriasis: drug trial underway
Disease control CompletedThis study tests a drug called certolizumab pegol (Cimzia) in children aged 6 to 17 with moderate to severe plaque psoriasis. The goal is to see how the drug moves through the body and whether it is safe. Some children will get the drug, others a placebo. The study is active but …
Phase: PHASE3 • Sponsor: UCB Biopharma SRL • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
Wart war: which treatment wins – acid, fungus extract, or both?
Disease control CompletedThis study tested three ways to treat warts: a topical acid solution, injections of candida antigen (a yeast extract), and a combination of both. 126 people with warts took part. The goal was to see which approach cleared warts best, including warts not directly treated, and how …
Phase: PHASE2 • Sponsor: Benha University • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
Can anifrolumab calm the painful boils of HS? a new trial seeks answers.
Disease control CompletedThis study tests whether anifrolumab, an antibody drug, can reduce skin abscesses and nodules in people with hidradenitis suppurativa (HS). Fifteen adults with moderate-to-severe HS will receive the drug intravenously over 24 weeks. The main goal is to see if at least half of par…
Phase: PHASE2 • Sponsor: University of North Carolina, Chapel Hill • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
Can a new antibody calm severe eczema?
Disease control CompletedThis phase II trial is testing whether an experimental drug called MG-K10 can reduce the severity of moderate-to-severe atopic dermatitis, a chronic inflammatory skin condition. About 60 adults who have not responded well to topical treatments will receive either MG-K10 or a plac…
Phase: PHASE2 • Sponsor: Shanghai Mabgeek Biotech.Co.Ltd • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
New oral pill HPP737 takes on psoriasis in Head-to-Head trial
Disease control CompletedThis Phase 3 trial tests whether an experimental oral drug, HPP737, can reduce psoriasis severity in adults with moderate-to-severe plaque psoriasis. Participants take HPP737 or an active control drug daily for 16 weeks. Researchers measure skin clearance using standard scores li…
Phase: PHASE3 • Sponsor: Newsoara Biopharma Co., Ltd. • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
New oral pill HPP737 aims to clear psoriasis in phase 3 trial
Disease control CompletedThis Phase 3 trial tests whether an oral drug called HPP737 can safely improve moderate-to-severe plaque psoriasis in adults. Participants take HPP737 or a placebo daily for 16 weeks, with doctors measuring skin clearance using standard scores like PASI. The study aims to see if …
Phase: PHASE3 • Sponsor: Newsoara Biopharma Co., Ltd. • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
New psoriasis drug shows promise for teens in early trial
Disease control CompletedThis study tested two doses of bimekizumab, a drug that targets inflammation, in 41 adolescents aged 12 to 17 with moderate to severe plaque psoriasis. The main goals were to measure how the drug behaves in the body and to check its safety. Researchers also looked at how well it …
Phase: PHASE2 • Sponsor: UCB Biopharma SRL • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
Could a stronger antibiotic dose keep cellulitis patients out of hospital?
Disease control CompletedThis study tests whether a higher dose of the oral antibiotic cephalexin can better treat cellulitis, a common skin infection, in adults visiting the emergency room. About 446 participants will receive either a high or standard dose to see if it reduces the need for changing anti…
Phase: PHASE4 • Sponsor: Ottawa Hospital Research Institute • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
New oral pill HPP737 aims to clear psoriasis in phase II trial
Disease control CompletedThis trial tests whether an oral drug called HPP737 can safely improve moderate-to-severe plaque psoriasis in adults. Participants take either HPP737 or a placebo daily for 85 days. Researchers measure skin improvement using standard scoring tools and track any side effects. The …
Phase: PHASE2 • Sponsor: Newsoara Biopharma Co., Ltd. • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
Can a vacuum chamber help heal stubborn leg wounds?
Disease control CompletedThis trial tests whether adding vacuum compression therapy — a device that applies cycles of pressure and suction to the leg — can improve healing of chronic lower limb ulcers. Adults with ulcers that have not healed despite standard care will receive either standard wound care a…
Phase: NA • Sponsor: BTL Industries Ltd. • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
Cucumber seed gel put to the test as a natural sunburn shield
Disease control CompletedThis trial tests whether a gel made from cucumber seed extract can protect skin from sunburn. Healthy Filipino adults with medium to tan skin types will have the gel and a placebo applied to different spots on their lower back, followed by controlled UV light exposure. The next d…
Phase: NA • Sponsor: DOH - Tondo Medical Center • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
Can a drug and heat combo beat a parasitic skin disease?
Disease control CompletedThis trial tests whether a drug called miltefosine, heat therapy (thermotherapy), or both together can safely and effectively treat skin lesions caused by the Leishmania tropica parasite in Pakistan. About 645 adults with up to four skin sores will be randomly assigned to one of …
Phase: PHASE3 • Sponsor: Medecins Sans Frontieres, Netherlands • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC
-
Can a shorter gel wait time still clear precancerous spots?
Disease control CompletedThis trial tests whether a lower-strength light-activated gel (8% vs. 16%) and a shorter wait time before red light treatment (1 hour vs. 3 hours) can effectively clear actinic keratoses—rough, precancerous spots caused by sun damage—on the face. Participants will receive one of …
Phase: NA • Sponsor: University of Nove de Julho • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC
-
Ancient herbal mix put to the test against psoriasis
Disease control CompletedThis phase 2 trial tests whether a Chinese medicine formula called Inflammatory Skin Disease Formula (ISDF) can reduce the severity of plaque psoriasis, a common inflammatory skin condition. Adults with mild to moderate psoriasis will take either ISDF granules or a placebo twice …
Phase: PHASE2 • Sponsor: Chinese University of Hong Kong • Aim: Disease control
Last updated Jul 29, 2026 00:00 UTC
-
Ancient herbal mix put to the test against childhood eczema
Disease control CompletedThis pilot study tests whether a modified Chinese herbal formula, Modified Huang-Lian-Jie-Du Decoction (MHLJDD), can reduce eczema symptoms in children aged 4 to 17. Participants take either the herbal granules or a placebo twice daily for 12 weeks. The study measures changes in …
Phase: PHASE1, PHASE2 • Sponsor: Chinese University of Hong Kong • Aim: Disease control
Last updated Jul 29, 2026 00:00 UTC
-
Can light therapy or special skincare tame rosacea redness? a trial puts them to the test
Disease control CompletedThis study compares three ways to reduce facial redness in adults with a common form of rosacea: intense pulsed light (IPL) treatments alone, a professional anti-redness skincare regimen alone, or both combined. Researchers will use both doctor ratings and advanced skin-imaging t…
Phase: NA • Sponsor: Medical University of Silesia • Aim: Disease control
Last updated Jul 29, 2026 00:00 UTC
-
Ancient herb mix put to the test against stubborn hives
Disease control CompletedThis phase 2 trial tests whether a modified version of the traditional Chinese herbal formula Xiao-Feng Powder can reduce itching and wheals in people with chronic urticaria (hives lasting more than 6 weeks). About 58 adults will receive either the herbal granules or a placebo tw…
Phase: PHASE2 • Sponsor: Prof. Lin Zhixiu • Aim: Disease control
Last updated Jul 29, 2026 00:00 UTC
-
Friendly bacteria vs. yeast: can a probiotic stop infections from coming back?
Disease control CompletedThis trial tests whether taking a specific probiotic supplement (Lactobacillus crispatus Lc-G22) alongside standard antifungal treatment can help prevent repeat vaginal yeast infections. One hundred women with a history of frequent yeast infections will receive either the probiot…
Phase: NA • Sponsor: BioGrowing Co., Ltd • Aim: Disease control
Last updated Jul 29, 2026 00:00 UTC
-
Can a targeted immune drug calm rare muscle inflammation?
Disease control CompletedThis trial tests whether efgartigimod, an injected drug that blocks certain immune antibodies, can improve muscle strength and function in adults with active idiopathic inflammatory myopathy — a group of rare autoimmune diseases that cause muscle inflammation and weakness. About …
Phase: PHASE2, PHASE3 • Sponsor: argenx • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Could microneedling make scar treatment less painful and more effective?
Disease control CompletedThis trial tests whether applying the drug 5-fluorouracil through microneedling works better than standard injections of the same drug or corticosteroids for treating hypertrophic scars and keloids. About 60 adults with these raised scars will receive one of four treatments. Rese…
Phase: PHASE4 • Sponsor: Alexandria University • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Which antifungal cream works best for stubborn skin fungus? a Head-to-Head trial aims to find out
Disease control CompletedThis trial compares two common antifungal creams — oxiconazole 1% and clotrimazole 1% — to see which works better for treating dermatophytosis, a fungal skin infection often called ringworm. About 164 adults with mild to moderate infections will apply one of the creams daily. The…
Phase: NA • Sponsor: Shalamar Institute of Health Sciences • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
New oral pill TLL018 aims to clear psoriasis plaques in phase 2 trial
Disease control CompletedThis phase 2 trial tests whether an experimental oral drug called TLL018 can improve skin clearance in adults with moderate-to-severe plaque psoriasis. Participants receive one of two doses of TLL018 or a placebo for 12 weeks. The main goal is to see if at least 75% of skin plaqu…
Phase: PHASE2 • Sponsor: Hangzhou Highlightll Pharmaceutical Co., Ltd • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
New biologic drug aims to clear stubborn eczema in just 24 weeks
Disease control CompletedThis study tests whether lebrikizumab, an injectable biologic, can improve skin symptoms in adults and adolescents (aged 12 and older) with moderate-to-severe atopic dermatitis, also known as eczema. Participants receive lebrikizumab for 24 weeks, and doctors measure changes in e…
Phase: PHASE3 • Sponsor: Almirall, S.A. • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
New oral drug aims to tame severe eczema in teens
Disease control CompletedThis study tests an experimental oral medication called QY201 in adolescents aged 12 to 17 with moderate to severe atopic dermatitis (eczema). Participants take either 10 mg or 20 mg of QY201 twice daily for 28 days. The main goal is to understand how the drug moves through the b…
Phase: PHASE2 • Sponsor: E-nitiate Biopharmaceuticals (Hangzhou) Co., Ltd. • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
Head-to-Head: which pill tames hidradenitis suppurativa best?
Disease control CompletedThis study compares two oral drugs, apremilast and acitretin, to see which works better for moderate-to-severe hidradenitis suppurativa, a painful skin condition. About 70 adults take one of the two pills twice daily for 12 weeks. The main goal is to measure how much the disease …
Phase: PHASE4 • Sponsor: Hayat Abad Medical Complex, Peshawar • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
New melanoma drug aims to match Keytruda's success
Disease control CompletedThis phase 3 trial compares a new drug, RPH-075, to the established immunotherapy Keytruda (both are forms of pembrolizumab) in people with advanced or spreading skin melanoma that cannot be surgically removed. The study aims to see if RPH-075 is as effective as Keytruda at shrin…
Phase: PHASE3 • Sponsor: R-Pharm • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
Can a common antibiotic beat yaws? new trial puts linezolid to the test
Disease control CompletedThis phase 3 trial investigates whether the antibiotic linezolid can cure yaws, a bacterial skin infection that causes ulcers, as effectively as the standard treatment azithromycin. The study involves 384 children aged 5 to 18 with confirmed yaws. Participants receive either line…
Phase: PHASE3 • Sponsor: Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
Could a cheaper copy of keytruda work just as well against cancer?
Disease control CompletedThis study tests whether a new drug called RPH-075, a biosimilar of pembrolizumab (Keytruda), works as well as the original in people with skin melanoma, lung cancer, or head and neck cancer. Participants receive a single dose of either RPH-075 or Keytruda, and researchers compar…
Phase: PHASE1 • Sponsor: R-Pharm • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
Experimental drug aims to halt scarring hair loss
Disease control CompletedThis pilot study tests an experimental drug called ritlecitinib in people with cicatricial alopecia, a type of hair loss where hair follicles are permanently destroyed and replaced by scar tissue. The drug works by blocking certain enzymes involved in inflammation. Researchers wi…
Phase: PHASE2 • Sponsor: Emma Guttman • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
New oral drug could offer hope for Tough-to-Treat eczema
Disease control CompletedThis phase 2 study tests whether rilzabrutinib, an oral medication, can reduce eczema severity in adults with moderate-to-severe atopic dermatitis who do not respond well to or cannot tolerate topical corticosteroids. Participants receive either rilzabrutinib or a placebo for 16 …
Phase: PHASE2 • Sponsor: Sanofi • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Wobbly workouts may sharpen basketball Players' moves
Disease control CompletedThis trial compares unstable resistance training (exercises on unstable surfaces like balance pads) with traditional resistance training in male college basketball players. The goal is to see if the unstable version improves dynamic balance and the ability to quickly change direc…
Phase: NA • Sponsor: Richen Sun • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Fat stem cells and light may restore skin color in vitiligo
Disease control CompletedThis study tests whether injecting a person's own fat-derived stem cells into stable vitiligo patches, alone or combined with excimer light therapy, can safely bring back skin color. Fifteen adults with stable vitiligo patches will receive the treatment. The goal is to see if the…
Phase: NA • Sponsor: Tanta University • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Could a daily postbiotic help fight yeast infections?
Disease control CompletedThis trial investigates whether taking a postbiotic supplement daily for four weeks can help ease symptoms of vaginal yeast infections in women. Participants are sexually active women with a confirmed yeast infection. The study compares the postbiotic to a placebo to see if it im…
Phase: PHASE2, PHASE3 • Sponsor: Min-Tze LIONG • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
New cream shows promise for clearing psoriasis in chinese patients
Disease control CompletedThis Phase 3 study tests a cream called roflumilast (Zoryve) for treating plaque psoriasis in Chinese patients aged 6 years and older. The cream is applied once daily to reduce skin plaques. Researchers will measure how many patients achieve clear or almost clear skin after 8 wee…
Phase: PHASE3 • Sponsor: Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Playtime power: structured games may sharpen young minds and bodies
Disease control CompletedThis study tests whether structured physical games can improve memory, attention, gross motor skills, and social adaptability in children aged 4 to 6. Over 8 weeks, preschoolers play specially designed games like 'Eagle Catching Chicks' and 'Puppy Seeking Bones' during class. Res…
Phase: NA • Sponsor: Shenzhen University • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
New drug aims to tame severe eczema in kids and teens
Disease control CompletedThis study tests an experimental drug called SHR-1819 in children and adolescents aged 6 to 17 with moderate-to-severe atopic dermatitis (a type of eczema). The main goal is to check the drug's safety and how the body processes it. Researchers will also look at changes in skin-re…
Phase: PHASE1, PHASE2 • Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Could a Two-Drug punch wipe out melanoma before surgery?
Disease control CompletedThis phase 2 pilot study tests whether adding the investigational drug vidutolimod to the immunotherapy nivolumab can destroy more melanoma tumors in lymph nodes or nearby skin areas before surgery. Participants have stage IIIB/C/D melanoma that has spread but not to distant orga…
Phase: PHASE2 • Sponsor: Diwakar Davar • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Shorter wait for light therapy? study tests faster treatment for Sun-Damaged skin
Disease control CompletedThis study compares two different incubation times for a light-activated cream used to treat actinic keratosis, a common precancerous skin condition caused by sun exposure. Participants receive either no wait or a one-hour wait after applying the cream before blue light therapy. …
Phase: NA • Sponsor: Northwestern University • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Can interferon keep melanoma from coming back after surgery?
Disease control CompletedThis completed phase 2 trial tested whether adding alpha interferon to standard surgery helps prevent skin melanoma from returning. 278 participants with stage I-IV melanoma were assigned to one of six groups, including surgery alone, low or high dose interferon, chemotherapy, or…
Phase: PHASE2 • Sponsor: MIPO Clinic • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Stem cell shot aims to heal stubborn leg wounds
Disease control CompletedThis early study tested a single topical dose of stem cells (XSTEM-VLU) in 6 people with difficult-to-heal venous leg ulcers. The goal was to check safety and see if the treatment helps wounds close faster when added to standard care. Participants were followed for 10 weeks after…
Phase: PHASE1, PHASE2 • Sponsor: Xintela AB • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
New shot shows promise for tough eczema in major trial
Disease control CompletedThis phase 3 study tested a drug called rocatinlimab in 726 adults with moderate-to-severe atopic dermatitis (eczema) that wasn't well controlled by creams. Participants received either the drug or a placebo as a shot under the skin for 24 weeks. The main goals were to see if the…
Phase: PHASE3 • Sponsor: Amgen • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
Rare disease drug shows promise in reducing infections
Disease control CompletedThis study tested two drugs, plerixafor and G-CSF, in 20 people with WHIM syndrome, a rare genetic condition that causes frequent infections and warts. Participants received each drug for a year and tracked their infections. The goal was to see which drug better reduced infection…
Phase: PHASE2, PHASE3 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
Can a vaccine keep melanoma from coming back? large trial tests immune boosters
Disease control CompletedThis phase 3 trial tested whether a yeast-derived immune stimulant (GM-CSF) and a peptide vaccine, alone or together, could prevent melanoma from returning after surgery. 815 patients with no visible cancer after complete surgical removal of advanced melanoma were randomly assign…
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
New shot could tame severe eczema in kids
Disease control CompletedThis study tested a drug called nemolizumab in 109 children aged 2 to 11 with moderate-to-severe eczema. The drug is given as a shot under the skin every 4 weeks for a year. Researchers measured how the drug moves through the body, its safety, and whether it improves eczema sympt…
Phase: PHASE2 • Sponsor: Galderma R&D • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New serum combo takes on stubborn toenail fungus
Disease control CompletedThis completed study tested two topical serums for treating toenail fungus (onychomycosis). 44 adults with mild to moderate infection applied one or both serums daily for 112 days. Researchers measured the change in healthy nail area using photos. The goal was to see if using bot…
Phase: NA • Sponsor: Swiss Footcare Laboratories - Poderm Professional • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Psoriasis drug guselkumab under microscope in new immune study
Disease control CompletedThis study is testing how the drug guselkumab affects the immune system in people with two types of psoriasis: plaque and guttate. Twenty-five adults will receive guselkumab injections over 44 weeks. Researchers will measure changes in immune cells in the skin to understand how t…
Phase: PHASE4 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Lab-grown stem cells may restore damaged eye surfaces
Disease control CompletedThis study tests whether a graft made from a patient's own or donor stem cells can repair the cornea's surface in people with limbal stem cell deficiency, a condition that causes pain, scarring, and vision loss. A small biopsy of limbal tissue is taken from a healthy eye or donor…
Phase: NA • Sponsor: Veerle Van Gerwen • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Needle-Free light therapy shows promise for common skin cancer
Disease control CompletedThis study tested a new way to treat basal cell carcinoma, a common skin cancer. Instead of surgery, doctors used a jet-injection device to deliver a drug called ALA into the tumor, then activated it with red light. The trial included 16 adults with small, low-risk BCCs and aimed…
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Herbal ointment shows promise for eczema relief
Disease control CompletedThis completed trial tested a herbal ointment made from Syzygium formosum leaves in 90 people with mild to moderate atopic dermatitis (eczema). The ointment was compared to standard moisturizers to see if it was safe and effective. The study measured skin severity, water loss, an…
Phase: NA • Sponsor: VinUniversity • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Could a single pill cure scabies? new study tests three doses
Disease control CompletedThis study tested whether a single dose of an oral drug called moxidectin can cure scabies, a skin condition caused by tiny mites. 200 adults with confirmed scabies received either 8 mg, 16 mg, or 32 mg of moxidectin or a placebo. The main goal was to see if the drug could comple…
Phase: PHASE2 • Sponsor: Medicines Development for Global Health • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Acne Treatment's Oil-Reducing power put to the test
Disease control CompletedThis study investigates whether clascoterone cream 1%, an FDA-approved acne medication, works by reducing sebum (skin oil) production. Researchers will measure forehead oil levels and changes in skin bacteria in 40 participants aged 12 and older with mild to moderate acne. The go…
Phase: PHASE4 • Sponsor: Sun Pharmaceutical Industries Limited • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Can a video call heal wounds? telemedicine takes on chronic sores
Disease control CompletedThis study tests whether using telemedicine (remote doctor visits) helps heal chronic wounds better than usual in-person care. Adults with long-lasting wounds in the Languedoc-Roussillon region of France are randomly assigned to telemedicine or standard treatment. The main goal i…
Phase: NA • Sponsor: University Hospital, Montpellier • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Could a drug plus light therapy reverse vitiligo? new trial tests the combo
Disease control CompletedThis phase 2 trial tested whether adding the oral drug baricitinib to phototherapy (light treatment) helps restore skin color in adults with progressive vitiligo. 49 participants received either baricitinib plus phototherapy or a placebo plus phototherapy for 36 weeks. The main g…
Phase: PHASE2 • Sponsor: University Hospital, Bordeaux • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
New drug cocktail aims to tackle rare blood cancer
Disease control CompletedThis phase 2 trial tested whether combining two drugs, romidepsin and lenalidomide, is safe and effective for people with peripheral T-cell lymphoma (PTCL) who haven't had treatment yet. PTCL is a rare blood cancer with no standard therapy, and current options like CHOP chemother…
Phase: PHASE2 • Sponsor: Northwestern University • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
New shot could ease painful skin condition
Disease control CompletedThis study tested a drug called sonelokimab in 418 adults with moderate to severe hidradenitis suppurativa, a skin condition that causes painful lumps and abscesses. Participants received either the drug or a placebo injection for 16 weeks. The goal was to see if sonelokimab redu…
Phase: PHASE3 • Sponsor: MoonLake Immunotherapeutics AG • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Teens with rare swelling disorder get new drug tested
Disease control CompletedThis study looked at how a new oral medication (sebetralstat) works in the bodies of 11 teenagers aged 12 to 17 with hereditary angioedema (HAE) types I or II. The goal was to measure drug levels and timing in the blood. All participants were already in a larger HAE trial. The st…
Phase: PHASE3 • Sponsor: KalVista Pharmaceuticals, Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Eczema drug upadacitinib under Real-World safety check in china
Disease control CompletedThis study looks at how safe and effective upadacitinib is for Chinese adolescents and adults with moderate to severe atopic dermatitis (eczema). About 200 participants will take the drug as prescribed by their doctor and be followed for up to 24 months. The goal is to track seri…
Sponsor: AbbVie • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Sound waves and gel team up to heal stubborn leg ulcers
Disease control CompletedThis study tested a new way to treat venous leg ulcers, which are slow-healing wounds on the lower leg. Researchers used ultrasound to push hyaluronic acid gel into the wound and compared it to standard care in 64 patients. The goal was to see if this combination speeds up healin…
Phase: NA • Sponsor: Cairo University • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Can a blood flow drug ease painful finger ulcers in scleroderma?
Disease control CompletedThis study tested the drug bosentan in 18 adults with systemic sclerosis who had reduced blood flow in their hands and a history of digital ulcers. The goal was to see if bosentan could improve hand blood flow measured by laser imaging and how blood flow relates to ulcer severity…
Phase: PHASE4 • Sponsor: Actelion • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Amniotic membrane wraps show promise for stubborn wounds
Disease control CompletedThis study looked at whether special wraps made from human amniotic membrane can help heal chronic wounds like diabetic foot ulcers, venous leg ulcers, and pressure ulcers. Researchers reviewed data from 500 patients who either received the membrane wraps or standard wound care. …
Sponsor: BioLab Holdings • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
New gel scaffold aims to improve healing after skin cancer removal
Disease control CompletedThis study tested a new gel-like wound dressing called MAP Wound Matrix (TT101) in 40 adults who had skin cancer removed with Mohs surgery. The dressing was applied right after surgery to see if it was safe and helped wounds heal compared to a standard hydrocolloid bandage. The m…
Phase: NA • Sponsor: Tempo Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
Eczema drug nemolizumab put to the vaccine test
Disease control CompletedThis study looked at whether nemolizumab, a drug for moderate-to-severe eczema, interferes with the body's ability to respond to tetanus and meningococcal vaccines. 242 adults and teens with eczema received either nemolizumab or a placebo, plus the vaccines. The goal was to see i…
Phase: PHASE2 • Sponsor: Galderma R&D • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Eczema drug shows promise in repairing skin barrier
Disease control CompletedThis study looked at how the drug abrocitinib affects the skin barrier in 20 adults with moderate to severe atopic dermatitis (eczema). Researchers measured water loss from the skin and changes in skin-related genes at 2 and 12 weeks. The goal was to see if the treatment helps re…
Sponsor: Prof. Dr. Stephan Weidinger • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New surgical trick may improve nose shape after cleft lip repair
Disease control CompletedThis study tested a surgical technique called a dermal roll flap to support the nostril base in 45 people who had a previous cleft lip repair. The flap uses extra skin from the lip to lift and stabilize the nostril on the cleft side. Researchers measured changes in nostril positi…
Phase: NA • Sponsor: King Edward Medical University • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Selective immune cell removal may tame transplant complications
Disease control CompletedThis study tested whether removing a specific type of immune cell (naïve T cells) from donor stem cell grafts could prevent graft-versus-host disease (GVHD) after a stem cell transplant for blood cancers. The trial enrolled 84 patients who received high- or medium-intensity chemo…
Phase: PHASE2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Can bosentan reverse lung artery thickening? small study investigates
Disease control CompletedThis study looked at whether bosentan (Tracleer) can reduce the thickness of lung artery walls in people with a type of high blood pressure in the lungs (pulmonary arterial hypertension, or PAH). Eleven adults with PAH took bosentan for 6 months. Researchers measured artery wall …
Phase: PHASE4 • Sponsor: Actelion • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New drug XTX202 tested in patients with advanced cancers
Disease control CompletedThis study tested a new drug called XTX202 in 95 people with advanced solid tumors that had not responded to standard treatments. The goal was to check safety, find the right dose, and see if the drug could shrink tumors. The trial is now complete.
Phase: PHASE1, PHASE2 • Sponsor: Xilio Development, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
New drug combo may make cord blood transplants safer for blood cancer patients
Disease control CompletedThis study tested whether adding the drug tocilizumab to standard care could reduce the risk of graft-versus-host disease (GVHD) after a cord blood transplant in adults with blood cancers. GVHD is a serious complication where donor cells attack the patient's body. Tocilizumab blo…
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
New pill could stop hives from scratching or cold
Disease control CompletedThis phase 2a trial tested an oral drug called EVO756 in 30 adults with chronic inducible urticaria, a condition where physical triggers like scratching or cold cause hives. The study aimed to see if the drug is safe and can reduce wheals. Results are not yet available.
Phase: PHASE2 • Sponsor: Evommune, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Could vitamin d help clear acne? new trial tests the idea
Disease control CompletedThis completed trial tested whether adding vitamin D supplements to standard acne treatment (azithromycin and a topical retinoid) improves acne more than standard treatment alone. Fifty-eight people aged 13 to 40 with acne vulgaris took part. The main goal was to see if the combi…
Phase: NA • Sponsor: HITEC-Institute of Medical Sciences • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New eczema drug shows promise in 2-Year extension trial
Disease control CompletedThis study looked at the long-term safety and effectiveness of lebrikizumab for adults and teens with moderate-to-severe atopic dermatitis (eczema). Participants who completed a previous year-long study could join this 2-year extension. The main goal was to see how many people st…
Phase: PHASE3 • Sponsor: Almirall, S.A. • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New hope for rare gut disease? small study tests biologic drug
Disease control CompletedThis study tested a drug called ustekinumab in 8 people with a rare, severe form of Behçet's syndrome affecting the gut, along with a blood disorder called myelodysplastic syndrome. The goal was to see if the drug could control gut symptoms and reduce disease activity over 24 wee…
Phase: PHASE2 • Sponsor: Liu Tian • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New light therapy takes on stubborn toenail fungus
Disease control CompletedThis study tested two treatments for toenail fungus in 27 Asian adults: a light-activated dye (methylene blue photodynamic therapy) and a medicated nail polish (amorolfine). The goal was to see which worked better and was safer. Participants received either the light treatment or…
Phase: NA • Sponsor: Chulalongkorn University • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Cancer drug shows promise for rare skin disease
Disease control CompletedThis study tested whether imatinib, a drug used for certain cancers, can reduce skin hardening in people with severe scleroderma. 28 adults received either imatinib or a placebo for 6 months. The main goal was to see if the drug improved skin thickness and quality of life.
Phase: PHASE2 • Sponsor: University Hospital, Bordeaux • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Real-world dupixent study tracks eczema improvement in 305 canadians
Disease control CompletedThis study followed 305 Canadian adults and children (ages 6+) with moderate-to-severe eczema who were prescribed Dupixent as part of their routine care. Researchers measured how many patients achieved at least a 75% reduction in eczema severity after 6, 12, and 18 months. The go…
Sponsor: Sanofi • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Can a viagra drug heal scleroderma finger sores?
Disease control CompletedThis study tested whether sildenafil (the drug in Viagra) can help heal painful finger ulcers in people with scleroderma, a disease that damages blood vessels. 84 participants took either sildenafil or a placebo three times daily for 90 days. The main goal was to see if the ulcer…
Phase: PHASE3 • Sponsor: University Hospital, Lille • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Cheap drugs may tame severe sun allergy
Disease control CompletedThis completed study tested two older, low-cost drugs—methotrexate and azathioprine—against chronic actinic dermatitis, a painful skin reaction to sunlight. Fifty adults were randomly assigned to one drug for 24 weeks. Researchers tracked eczema severity and safety. The goal was …
Phase: EARLY_PHASE1 • Sponsor: Pak Emirates Military Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
New pill shrinks tough skin cancers in early trial
Disease control CompletedThis Phase II trial tested the drug vismodegib in 104 people with advanced basal cell carcinoma, a type of skin cancer that had spread or could not be surgically removed. Participants took a daily capsule until their cancer worsened or side effects became too severe. The study me…
Phase: PHASE2 • Sponsor: Genentech, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Could an antibody fight both psoriasis and heart disease?
Disease control CompletedThis phase 2 trial tested a drug called orticumab in 77 adults with moderate-to-severe psoriasis who also had cardiometabolic risks (like obesity and high cholesterol). The goal was to see if orticumab could safely reduce skin plaques and inflammation linked to heart disease. Par…
Phase: PHASE2 • Sponsor: Abcentra • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Simple map may end painful insulin lumps for diabetes patients
Disease control CompletedThis study tested a visual injection site map to help people with diabetes rotate where they inject insulin. The goal was to reduce lipohypertrophy—lumpy fatty tissue caused by repeated shots in the same spot—and improve blood sugar control. 170 adults on insulin for at least six…
Phase: NA • Sponsor: Helwan University • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
New drug navenibart aims to tame hereditary swelling attacks
Disease control CompletedThis early trial tested a new drug called navenibart in 29 people with hereditary angioedema (HAE), a condition that causes sudden, painful swelling attacks. Participants received one or two doses of the drug to check its safety and how well it might reduce attacks. The study is …
Phase: PHASE1, PHASE2 • Sponsor: Astria Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
New drug shows promise for controlling rare swelling disorder
Disease control CompletedThis study tested the long-term safety and effectiveness of donidalorsen, an injectable drug, in 20 people with hereditary angioedema (HAE), a condition that causes sudden, painful swelling attacks. Participants received different doses over 64 weeks. The main goal was to check f…
Phase: PHASE2 • Sponsor: Ionis Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
No-Needle chemo patch takes aim at skin cancer
Disease control CompletedThis study tested a microneedle patch that delivers the chemotherapy drug doxorubicin directly into nodular basal cell carcinoma, a common skin cancer. 90 adults with small, untreated tumors received either a low-dose, high-dose, or no-drug patch. The goal was to see if the patch…
Phase: PHASE2 • Sponsor: SkinJect, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Promising drug tackles rare eye disease that leads to blindness
Disease control CompletedThis early-phase trial tested the drug rituximab in 3 people with ocular cicatricial pemphigoid, a rare autoimmune disease that causes scarring in the eye and can lead to blindness. The goal was to see if the drug could stop further scarring when standard treatments had failed. T…
Phase: PHASE1, PHASE2 • Sponsor: University of Alabama at Birmingham • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
High-Dose chemo and stem cell transplant shows promise for HIV lymphoma patients
Disease control CompletedThis early-phase trial tested whether high-dose chemotherapy followed by a stem cell transplant is safe and feasible for 25 people with HIV who also have lymphoma. The goal was to see how well the body recovers and to monitor side effects. Results could point to a new treatment p…
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Light shines on fungus: new device tackles toenail infection
Disease control CompletedThis study tested a light therapy device called ToeFX for mild to moderate toenail fungus. 126 people with fungal infection in one big toenail used the device. Researchers measured new clear nail growth after 12 months to see if the treatment worked and was safe.
Phase: NA • Sponsor: ToeFX Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Old drug, new hope for right heart failure?
Disease control CompletedThis study tested the drug spironolactone in 15 adults with chronic right-sided heart failure. The goal was to see if it is safe and can improve heart function and reduce stress on the heart. Participants took either the drug or a placebo to compare effects.
Phase: PHASE4 • Sponsor: Ottawa Heart Institute Research Corporation • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New psoriasis pill shows promise in early trial
Disease control CompletedThis study tested an oral tablet called JNJ-77242113 in 90 adults with moderate-to-severe plaque psoriasis. Participants were randomly assigned to receive the drug or a placebo for 16 weeks. The main goal was to see if the drug could improve psoriasis symptoms by at least 75% com…
Phase: PHASE2 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Can a blood vessel drug save kidneys in scleroderma crisis?
Disease control CompletedThis study tested a drug called bosentan in 16 adults with scleroderma who had a serious kidney complication called scleroderma renal crisis. The goal was to see if bosentan could help protect kidney function and improve survival over 6 months to a year. The drug works by blockin…
Phase: PHASE2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
New hope for Tough-to-Treat psoriasis: guselkumab targets sensitive areas
Disease control CompletedThis completed phase 3 trial tested the drug guselkumab against a placebo in 338 adults with moderate plaque psoriasis covering only 2-15% of their body but including special sites like the scalp, face, or genitals. The goal was to see if guselkumab could clear or nearly clear ps…
Phase: PHASE3 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Can a lung drug stop COVID scarring?
Disease control CompletedThis study tested whether nintedanib, a drug used for other lung diseases, can slow down lung damage in people who had severe COVID-19. It included 103 adults who still had lung problems more than 30 days after their COVID diagnosis. The main goal was to see if the drug helped ma…
Phase: PHASE4 • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
Milder chemo before TIL therapy shows promise for tough-to-treat melanoma
Disease control CompletedThis phase 2 trial tested whether a reduced dose of chemotherapy drugs (fludarabine and cyclophosphamide) given before infusing a patient's own tumor-fighting immune cells (lifileucel) could work for advanced melanoma that has spread or can't be removed. Eleven adults with stage …
Phase: PHASE2 • Sponsor: University of Kansas Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
Which mattress heals bedsores faster? new study has answers
Disease control CompletedThis study tested two types of special mattresses—the Fluid Immersion Simulation (FIS) system and the Air Fluidized Bed (AFB)—to see which helps heal surgically closed pressure ulcers (bedsores) better. Eighty adults with stage III or IV bedsores were randomly assigned to one mat…
Phase: NA • Sponsor: Northwestern University • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
New shot shows promise for tough eczema in early trial
Disease control CompletedThis study tested a new drug called SHR-1819 in 158 adults with moderate to severe atopic dermatitis (a type of eczema). Participants received one of three doses of the drug or a placebo. The main goal was to see if the drug could reduce eczema severity by at least 75% after 16 w…
Phase: PHASE2 • Sponsor: Shanghai Hengrui Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
Skyrizi under the microscope: Real-World safety data on over 2,300 patients
Disease control CompletedThis study tracked over 2,300 adults in Korea who were prescribed Skyrizi (risankizumab) for moderate to severe plaque psoriasis or psoriatic arthritis. Researchers monitored side effects and symptom changes for 52 weeks during routine doctor visits. The goal was to confirm the d…
Sponsor: AbbVie • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
New antibody shows promise for rare blood cancers
Disease control CompletedThis phase 2 trial tested a drug called lacutamab (IPH4102) in 170 people with advanced T-cell lymphoma, including Sezary syndrome and mycosis fungoides. The drug is an antibody that targets a protein on cancer cells. It was given alone or with chemotherapy to see if it could shr…
Phase: PHASE2 • Sponsor: Innate Pharma • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
New study tests easier treatment for blistering skin disease
Disease control CompletedThis study tested two ways to treat bullous pemphigoid, a severe blistering skin condition. One group used strong steroid creams for 9 months, while the other used steroids plus methotrexate for 4 weeks, then methotrexate alone for 8 months. The goal was to see if the combination…
Phase: PHASE3 • Sponsor: University Hospital, Montpellier • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Can diet and exercise boost a psoriasis Drug's power?
Disease control CompletedThis study looked at 781 adults with moderate-to-severe plaque psoriasis and metabolic syndrome (a cluster of conditions like high blood pressure and obesity). Researchers wanted to see if adding a lifestyle intervention (diet and exercise) to the drug Secukinumab (Cosentyx) impr…
Phase: PHASE4 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Umbilical cord stem cells tested for rare lung condition
Disease control CompletedThis study tested a single intravenous infusion of stem cells from donated umbilical cord tissue in one person with severe scleroderma that had caused lung scarring and high blood pressure in the lungs. The goal was to see if the treatment could improve lung function, exercise ab…
Phase: PHASE1, PHASE2 • Sponsor: Fundación Neumologica Colombiana • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Drug combo slashes melanoma return risk in High-Risk patients
Disease control CompletedThis study tested whether taking two targeted drugs (dabrafenib and trametinib) for 12 months after melanoma surgery could keep the cancer from returning. It included 870 adults with high-risk stage III melanoma that had a specific BRAF V600 mutation. Results showed the drug comb…
Phase: PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Less invasive surgery shows promise for anal cancer in HIV patients
Disease control CompletedThis study looked at whether removing small, early-stage anal cancers with local surgery alone is safe and effective for people with HIV. The goal was to see if this less invasive approach could avoid the need for stronger treatments like radiation or chemotherapy. Sixteen partic…
Phase: PHASE2 • Sponsor: AIDS Malignancy Consortium • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
Eczema cream showdown: steroid vs Non-Steroid in kids
Disease control CompletedThis study tested two creams for mild to moderate eczema in 40 children aged 1-12. One cream was a steroid (fluticasone), the other a non-steroid (crisaborole). Both were applied twice daily for 6 weeks, then twice weekly for 12 weeks if the skin improved a lot. Both treatments w…
Phase: NA • Sponsor: Noura Abdelmoneim Mohammed Elseessy • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
Ear drop showdown: which works better for fungal infections?
Disease control CompletedThis study compared two ear drop treatments for otomycosis, a fungal infection of the outer ear that causes itching, discharge, and blockage. Sixty patients were randomly assigned to receive either clotrimazole or 2% salicylic acid drops three times daily for two weeks. The main …
Phase: NA • Sponsor: Mayo Hospital Lahore • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
New Two-Step transplant shows promise for blood cancer patients
Disease control CompletedThis study tested a two-step stem cell transplant for people with blood cancers like leukemia and lymphoma. First, patients received low-dose chemotherapy and radiation to prepare their bodies. Then, they got donor stem cells followed by drugs to prevent the donor cells from atta…
Phase: PHASE2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
One-Dose hope for blistering skin disease?
Disease control CompletedThis study tested whether a single cycle of rituximab can control bullous pemphigoid, a severe blistering skin condition. Eighteen adults with steroid-dependent or relapsing disease were enrolled. Researchers checked disease control weekly for a month and then monthly for two yea…
Phase: PHASE3 • Sponsor: University Hospital, Rouen • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
New shot shows promise for tough psoriasis cases
Disease control CompletedThis Phase 3 trial tested netakimab, a biologic drug given as a shot, against a placebo in 202 Chinese adults with moderate-to-severe plaque psoriasis. The main goal was to see if netakimab could improve skin symptoms by at least 75% (PASI75) or achieve clear/almost clear skin (s…
Phase: PHASE3 • Sponsor: SPH-BIOCAD (HK) Limited • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Placental grafts show promise for stubborn ulcers
Disease control CompletedThis study tested whether adding placental tissue grafts to standard wound care helps close diabetic foot and venous leg ulcers faster. 292 adults with nonhealing ulcers received either standard care alone or standard care plus a graft. The main goal was to see if more ulcers clo…
Phase: PHASE4 • Sponsor: Cellution Biologics • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
New gel helps stubborn wounds heal faster in real-world study
Disease control CompletedThis study followed 191 adults with chronic leg or foot ulcers that hadn't improved for at least 6 months. They received a gel called CACIPLIQ20 added to standard wound care. Researchers tracked how many wounds fully closed within 20 weeks and checked for side effects. The goal w…
Phase: NA • Sponsor: Organ, Tissue, Regeneration, Repair and Replacement • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Could a simple pill replace daily IV drips for skin infections?
Disease control CompletedThis study tested whether an oral antibiotic (moxifloxacin) works as well as a standard intravenous (IV) antibiotic (cefazolin) for treating moderate skin infections (cellulitis) in the emergency department. 390 patients with moderate cellulitis were treated either with daily IV …
Phase: PHASE3 • Sponsor: University of British Columbia • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Gum treatment may lower body inflammation and improve cholesterol
Disease control CompletedThis study looked at whether non-surgical gum disease treatment could reduce inflammation and improve blood fat levels in young adults with severe periodontitis. Fifty participants (25 with gum disease and 25 healthy) were involved. Those with gum disease received deep cleaning a…
Phase: NA • Sponsor: Istanbul University • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Could arthritis drug humira ease rare skin disease?
Disease control CompletedThis Phase 2 trial tested whether Humira (adalimumab), a drug used for arthritis, can help people with Netherton syndrome, a rare genetic skin condition that causes severe inflammation, itching, and pain. Eleven patients received six injections over three months, followed by thre…
Phase: PHASE2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
One pill could change the fight against sleeping sickness in kids
Disease control CompletedThis study tested a single dose of the oral drug acoziborole in 35 children aged 1 to 14 with sleeping sickness (g-HAT). The goal was to see how the drug works in the body and if it is safe and effective. This simpler treatment could help control the disease in remote areas where…
Phase: PHASE2, PHASE3 • Sponsor: Drugs for Neglected Diseases • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
New psoriasis ointment shows promise in large chinese trial
Disease control CompletedThis study tested a new ointment (LEO 90100) against a standard one (Daivobet) for stable plaque psoriasis in 604 Chinese adults. Participants applied the treatment for 4 weeks. The goal was to see if the new ointment could clear or nearly clear psoriasis patches better than the …
Phase: PHASE3 • Sponsor: LEO Pharma • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
New gel shows promise for ugly toenail fungus
Disease control CompletedThis study tested a special gel, CGB-400, on 15 adults with toenail fungus. The goal was to see if the gel could clear the fungus and make the nails look better. Participants applied the gel for 12 weeks, with follow-up visits to check progress.
Sponsor: CAGE Bio Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
Real-world study shows lanadelumab keeps HAE attacks at bay for many patients
Disease control CompletedThis study followed 48 people with hereditary angioedema (HAE) in Poland who were taking lanadelumab as part of a national drug program. Researchers tracked how many participants remained attack-free over 24 months, how many attacks still needed rescue treatment, and the severity…
Sponsor: Takeda • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
New drug combo shows promise for kids with rare immune disease
Disease control CompletedThis study tested a drug called alemtuzumab (Campath) as a first treatment for children with hemophagocytic lymphohistiocytosis (HLH), a rare and life-threatening immune disorder. The goal was to see if it could help children survive until they could receive a stem cell transplan…
Phase: PHASE1, PHASE2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
New shot shows promise for tough eczema in phase 3 trial
Disease control CompletedThis study tested a biologic drug called SIM0718 in 259 adults and teens with moderate to severe atopic dermatitis (eczema) that did not respond well to creams. Participants received either the drug or a placebo every two weeks for 16 weeks. The goal was to see if the drug could …
Phase: PHASE3 • Sponsor: Simcere Pharmaceutical Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
New eczema cream shows promise in tiny trial
Disease control CompletedThis completed Phase 2 trial tested a new ointment called CGB-500 (containing tofacitinib) against an approved cream (ruxolitinib) for atopic dermatitis, a type of eczema. Only 3 people aged 12 and older took part, applying both treatments to different skin areas twice daily for …
Phase: PHASE2 • Sponsor: CAGE Bio Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
New combo therapy aims to tame advanced melanoma
Disease control CompletedThis early-phase study tested whether adding a TNF-blocking drug (infliximab or certolizumab) to standard immunotherapy (nivolumab and ipilimumab) is safe for people with advanced melanoma that has spread. The main goal was to find the best dose and check for serious side effects…
Phase: PHASE1 • Sponsor: Institut Claudius Regaud • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
Bone drug may supercharge immunotherapy against tough melanoma
Disease control CompletedThis study tested whether adding denosumab (a bone-strengthening drug) to standard immunotherapy (pembrolizumab or nivolumab) could help control advanced melanoma that has spread. Researchers enrolled 25 adults with stage III or IV melanoma who had not received prior immunotherap…
Phase: PHASE2 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Can a pill plus light therapy restore skin color in vitiligo?
Disease control CompletedThis study tested whether the drug apremilast, taken as a pill twice daily, combined with narrowband UVB light therapy can help restore skin color in people with widespread vitiligo. 80 adults with stable or slowly progressing vitiligo covering at least 10% of their body took par…
Phase: PHASE2 • Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Zapping bedsores: could a gentle electric current help heal chronic wounds?
Disease control CompletedThis pilot study tested whether adding a special type of electrical stimulation to standard wound care helps heal chronic pressure injuries (bedsores) in people with spinal cord or brain injuries. Twenty adults with stage II-IV pressure sores that hadn't healed after four weeks o…
Phase: NA • Sponsor: Gaziler Physical Medicine and Rehabilitation Education and Research Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New cancer injection shows promise in early trial
Disease control CompletedThis early-stage study tested an experimental drug called JCXH-211, which is injected directly into tumors. It involved 19 adults with advanced solid tumors that had not responded to standard treatments. The main goals were to check safety and find the right dose, while also watc…
Phase: PHASE1 • Sponsor: Immorna Biotherapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New drug bimekizumab shows promise for psoriasis in early trial
Disease control CompletedThis Phase 2 trial tested the drug bimekizumab in 49 adults with moderate to severe plaque psoriasis. Participants received either bimekizumab or a placebo, and researchers measured how well the drug cleared skin and how long it stayed in the body. The goal was to see if bimekizu…
Phase: PHASE2 • Sponsor: UCB Biopharma SRL • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Radioactive bandage zaps skin cancer in early trial
Disease control CompletedThis early pilot study tested a new radioactive bandage called CivaDerm on 10 people with common skin cancers (basal cell or squamous cell carcinoma). The bandage delivers radiation directly to the skin surface, aiming to destroy cancer cells while sparing healthy tissue. The stu…
Phase: EARLY_PHASE1 • Sponsor: CivaTech Oncology • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New antibody shows promise for blistering skin disease
Disease control CompletedThis phase 2 trial tested avdoralimab, an antibody that blocks a specific immune signal, added to standard steroid cream for bullous pemphigoid—a severe blistering skin condition mostly affecting older adults. Fifteen participants received the combination to see if it leads to co…
Phase: PHASE2 • Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Stem cell transplant shows promise for scleroderma patients
Disease control CompletedThis study compared two treatment strategies for people with early, severe scleroderma: a stem cell transplant using their own cells versus standard immunosuppressive drugs. The trial enrolled 60 adults with diffuse cutaneous systemic sclerosis. The goal was to see which approach…
Phase: PHASE4 • Sponsor: UMC Utrecht • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Could a gel replace surgery for face melanoma?
Disease control CompletedThis study tested a gel called Picato (ingenol mebutate) on 20 people with a very early form of melanoma on the face, called lentigo maligna. Participants applied the gel once a day for three days. The goal was to see if the gel could make the cancer disappear completely, offerin…
Phase: PHASE2 • Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Can a cholesterol drug help stop vitiligo?
Disease control CompletedThis study tested whether adding the cholesterol drug atorvastatin to standard UVB light therapy works better than UVB alone for active vitiligo. 28 adults with active, non-segmental vitiligo took part. The main goal was to see if the combination reduced the amount of skin color …
Phase: PHASE2 • Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Laser treatment could offer new hope for chronic skin condition
Disease control CompletedThis study tested a new dual laser treatment for vulvar lichen sclerosus, a chronic skin condition causing discomfort. 66 participants were randomly assigned to receive either laser therapy or standard steroid cream. The goal was to see if the laser works as well as the cream, po…
Phase: NA • Sponsor: Prof. Dr. Volker Viereck • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Cream shows promise for genital vitiligo in early trial
Disease control CompletedThis phase 2 trial tested a cream called ruxolitinib (Opzelura) on 49 people with nonsegmental vitiligo affecting the genitals. Participants applied the cream twice daily for up to 48 weeks to see if it made the white patches less noticeable. The study measured success based on p…
Phase: PHASE2 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated Jun 27, 2026 11:04 UTC
-
New ankle machine could help athletes recover from sprains
Disease control CompletedThis study tested a new ankle training machine in 14 athletes with chronic ankle instability. The machine allows for multi-directional strengthening while sitting. Researchers compared it to standard resistance band training over six weeks, measuring muscle strength, balance, and…
Phase: NA • Sponsor: China Medical University Hospital • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
New hope for scleroderma: arthritis drug tofacitinib tested against skin thickening
Disease control CompletedThis study tested whether tofacitinib (a JAK inhibitor drug) works better than methotrexate (a standard treatment) at reducing skin thickening in people with a severe form of scleroderma called diffuse cutaneous systemic sclerosis. Thirty-four adults with early-stage disease took…
Phase: PHASE4 • Sponsor: Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
New combo shows promise for tough lymphomas
Disease control CompletedThis study tested adding lenalidomide to a standard chemotherapy regimen (EPOCH-R) in 55 people with aggressive B-cell lymphomas linked to the MYC gene. The goal was to find the best dose and see if the combination improves how long patients live without their cancer getting wors…
Phase: PHASE1, PHASE2 • Sponsor: University of Chicago • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Dose debate: which rituximab regimen works best for rare blistering disease?
Disease control CompletedThis study looked back at 275 pemphigus patients to see how different doses of rituximab affected disease control and relapse. Pemphigus is a rare autoimmune disease that causes painful blisters on skin and mucous membranes. Researchers tracked outcomes like flare-ups, side effec…
Sponsor: Ruijin Hospital • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New dressing shows promise for Hard-to-Heal wounds
Disease control CompletedThis study tested a special wound dressing called MicroMatrix Flex on 25 adults with deep or tunneled wounds, such as pressure injuries, diabetic ulcers, or infected wounds. The goal was to see how safely and quickly the dressing helped close these wounds over 12 weeks. Researche…
Phase: NA • Sponsor: Integra LifeSciences Corporation • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Could a simple breakfast replace the glucose drink for diabetes testing?
Diagnosis CompletedThis trial explores whether a standardized breakfast and a continuous glucose monitor can replace the traditional glucose drink test for diagnosing diabetes and prediabetes in people with Dunnigan's lipodystrophy, a rare genetic condition that causes severe insulin resistance. Th…
Phase: NA • Sponsor: Centre Hospitalier Universitaire de la Réunion • Aim: Diagnosis
Last updated Aug 08, 2026 00:03 UTC
-
Can a single tracer light up cancer's first stop? a trial puts a hybrid dye-and-radioactive marker to the test.
Diagnosis CompletedThis trial tests whether a new hybrid tracer, ICG-99mTc-nanoscan, can replace the standard tracer for sentinel node biopsy in people with penile cancer, melanoma, or oral cancer. The hybrid tracer combines a fluorescent dye with a radioactive marker, potentially allowing surgeons…
Phase: NA • Sponsor: The Netherlands Cancer Institute • Aim: Diagnosis
Last updated Jul 24, 2026 00:00 UTC
-
New imaging device aims to improve wound measurement
Diagnosis CompletedThis study tested a special camera called the MolecuLight DX that uses fluorescence to measure the size of skin wounds. 34 adults with various types of wounds (like diabetic foot ulcers) took part. The goal was to see if the device measures wound area more accurately than a stand…
Sponsor: MolecuLight Inc. • Aim: Diagnosis
Last updated Jun 27, 2026 14:02 UTC
-
Blood test may predict Behçet's flare-ups
Diagnosis CompletedThis study looked at whether a new blood test called the pan-immune-inflammation value (PIN) can help measure disease activity in people with Behçet's syndrome. Researchers compared 80 Behçet's patients to healthy controls. The goal is to find a simple, non-invasive way to monito…
Sponsor: Assiut University • Aim: Diagnosis
Last updated Jun 27, 2026 13:04 UTC
-
New french screening tool aims to catch eating disorders in athletes early
Diagnosis CompletedThis study is adapting and testing a French version of the Athletic Disordered Eating (ADE) scale, a 17-question screening tool designed specifically for athletes. Researchers will enroll 229 athletes aged 15 to 70 who exercise more than 6 hours per week. Participants complete th…
Phase: NA • Sponsor: University Hospital, Caen • Aim: Diagnosis
Last updated Jun 27, 2026 13:02 UTC
-
New imaging tool may help detect Eye-Area skin cancer without a biopsy
Diagnosis CompletedThis study tested a non-invasive imaging device called dermal optical coherence tomography (D-OCT) to diagnose basal cell carcinoma (a common skin cancer) around the eye area. Researchers compared its accuracy to standard biopsy results in 210 adults with suspected lesions. The g…
Sponsor: Vejle Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 12:37 UTC
-
New automatic device may speed up leg ulcer assessment
Diagnosis CompletedThis study compared an automatic ABPI device (MESI MD) with the standard manual device (Huntleigh Dopplex) in 46 patients with lower limb ulcers. The goal was to see if the automatic device gives similar scores and ulcer classifications, potentially reducing waiting times and dis…
Sponsor: University of Southampton • Aim: Diagnosis
Last updated Jun 27, 2026 12:35 UTC
-
New MRI method could spot lung damage without radiation
Diagnosis CompletedThis study tested whether MRI can detect and monitor interstitial lung disease (lung scarring) in people with scleroderma. Twenty-five adults with scleroderma underwent both MRI and CT scans. A subset also breathed in a special xenon gas to see how well their lungs exchange oxyge…
Sponsor: University of Kansas Medical Center • Aim: Diagnosis
Last updated Jun 27, 2026 12:28 UTC
-
New light device could spot skin cancer without a scalpel
Diagnosis CompletedThis study tested a non-invasive device that uses light to classify skin lesions as healthy, actinic keratosis, or carcinoma. Researchers aimed to see if it could help doctors diagnose skin conditions more accurately without needing a biopsy. The study involved 142 adults with su…
Phase: NA • Sponsor: Centre Hospitalier Régional Metz-Thionville • Aim: Diagnosis
Last updated Jun 27, 2026 12:23 UTC
-
Quick vaginal infection test could beat standard diagnosis
Diagnosis CompletedThis study tested whether a rapid point-of-care test (Xpert® Xpress MVP) helps doctors diagnose vaginal infections more accurately than usual methods. 351 women with symptoms like discharge or itching were randomly assigned to either usual care or the rapid test. Researchers then…
Phase: NA • Sponsor: Sharon L Hillier • Aim: Diagnosis
Last updated Jun 27, 2026 12:05 UTC
-
MRI may replace needle biopsy for muscle disease diagnosis
Diagnosis CompletedThis study looked at whether whole body MRI can accurately diagnose inflammatory myopathies—a group of muscle diseases causing weakness and damage. Researchers compared MRI results with muscle biopsies in 139 people suspected of having these conditions. If MRI proves reliable, it…
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Diagnosis
Last updated Jun 27, 2026 12:02 UTC
-
Smartphone AI could help doctors monitor skin disease remotely
Diagnosis CompletedThis study tested whether an artificial intelligence tool called Legit Health Plus can help doctors track the severity of chronic skin conditions like acne, psoriasis, and eczema from a distance. 160 participants used a smartphone app for 6 months to take photos of their skin and…
Sponsor: AI Labs Group S.L • Aim: Diagnosis
Last updated Jun 27, 2026 11:03 UTC
-
A simple nudge could boost shingles shots
Prevention CompletedThis trial tests whether sending reminder messages to older adults before a doctor's appointment can increase the number who get the shingles vaccine. The study will compare different message styles to see which is most effective. Participants are adults aged 50 and older who hav…
Phase: NA • Sponsor: Geisinger Clinic • Aim: Prevention
Last updated Aug 16, 2026 00:00 UTC
-
New program aims to protect young kenyan women from both HIV and partner violence
Prevention CompletedThis study tests a program called Tu'Washindi, designed by and for young women in Kenya. It combines support clubs and community sessions to help girls ages 15-24 reduce intimate partner violence and consistently use HIV prevention pills (PrEP). About 1,562 participants will be f…
Phase: NA • Sponsor: RTI International • Aim: Prevention
Last updated Aug 09, 2026 00:00 UTC
-
Can a single antibiotic dose cut child mortality in niger?
Prevention CompletedThis trial tests whether giving azithromycin—a common antibiotic—twice a year to young children in Niger can reduce deaths. It compares giving the drug to all children aged 1-59 months versus only to infants 1-11 months, who are at highest risk. The study also checks how these ap…
Phase: PHASE4 • Sponsor: University of California, San Francisco • Aim: Prevention
Last updated Aug 08, 2026 00:03 UTC
-
Which heel boot best shields against bedsores? a head-to-head test puts them to the test.
Prevention CompletedThis trial compares two heel protection boot devices — HeelMedix Basic and EHOB Waffle — to see which one better reduces pressure on the heel and calf. Healthy adults sit with one leg outstretched while a pressure-sensing mat measures how well each boot offloads pressure. The goa…
Sponsor: Medline Industries • Aim: Prevention
Last updated Jul 31, 2026 00:00 UTC
-
A simpler air mattress may prevent bedsores just as well — trial puts it to the test
Prevention CompletedThis trial compares two types of air mattresses for preventing pressure ulcers (bedsores) in hospital patients at high risk. One is a reactive static air mattress that stays still, and the other is an alternating air pressure mattress that constantly changes pressure points. Rese…
Phase: NA • Sponsor: Vitaz • Aim: Prevention
Last updated Jul 29, 2026 00:00 UTC
-
New air mattress aims to stop bedsores before they start
Prevention CompletedThis study looked at whether a powered alternating pressure air mattress can prevent pressure ulcers (bedsores) in patients at medium to high risk. 90 adults in nursing homes and long-term care used the mattress for up to 35 days. Researchers tracked how many developed at least a…
Sponsor: Nausicaa Medical • Aim: Prevention
Last updated Jun 27, 2026 12:29 UTC
-
Smartphone app aims to prevent bedsores and ease caregiver stress
Prevention CompletedThis study tested a mobile app designed to teach caregivers of bedridden patients how to prevent pressure injuries (bedsores). The app included educational modules, daily care tracking, and a way to ask a nurse questions. Researchers wanted to see if using the app for six months …
Phase: NA • Sponsor: Gündem Yakan Şahin • Aim: Prevention
Last updated Jun 27, 2026 12:29 UTC
-
Ice plant cream may shield cancer patients from chemo side effect
Prevention CompletedThis small pilot study tested whether an ice plant cream could prevent hand-foot syndrome (pain, redness, peeling on hands and feet) in 15 breast cancer patients receiving doxorubicin or docetaxel chemotherapy. The main goal was to see if a larger study is possible, not to prove …
Phase: NA • Sponsor: University Hospital Tuebingen • Aim: Prevention
Last updated Jun 27, 2026 12:29 UTC
-
Can a cream stop light from darkening your skin?
Prevention CompletedThis study tested seven different cosmetic creams to see if they could prevent skin darkening caused by high-energy visible light (like from the sun or screens). 33 healthy adults with fair to medium skin had creams applied to their back before being exposed to a specific blue-vi…
Sponsor: Cosmetique Active International • Aim: Prevention
Last updated Jun 27, 2026 12:08 UTC
-
Which cream wins? study tests two skin protectants against diaper rash in seniors
Prevention CompletedThis study tested two different skin protection products to prevent incontinence-associated dermatitis (a type of diaper rash) in elderly nursing home residents. Researchers compared a film-forming protectant and a lipophilic (oil-based) protectant against no treatment in 220 par…
Phase: NA • Sponsor: Charite University, Berlin, Germany • Aim: Prevention
Last updated Jun 27, 2026 11:02 UTC
-
Silk bandage vs. skin glue: which is gentler after ACL surgery?
Symptom relief CompletedThis study tests whether a special silk dressing (SYLKE®) causes fewer skin problems like rashes, blisters, or redness compared to standard skin glue (Dermabond®) after ACL knee surgery. About 100 people aged 14 to 60 having ACL reconstruction will be randomly assigned to one of …
Phase: NA • Sponsor: NYU Langone Health • Aim: Symptom relief
Last updated Aug 18, 2026 05:00 UTC
-
Ultrasound to reveal if cosmetic creams can melt away foot calluses and corns
Symptom relief CompletedThis study tests whether a cosmetic serum and cream containing urea, salicylic acid, and collagen can reduce the thickness and pain of foot calluses and corns. Adult women with a single callus or corn will apply the treatment twice daily for two months. High-frequency ultrasound …
Phase: NA • Sponsor: Wroclaw University of Health and Sport Sciences • Aim: Symptom relief
Last updated Aug 16, 2026 00:00 UTC
-
Could a skin patch ease stomach pain in scleroderma?
Symptom relief CompletedThis pilot study tests whether a transcutaneous electrical nerve stimulation (TENS) device is acceptable and helpful for people with scleroderma who experience gastroparesis symptoms like bloating and distension. Participants use the device for 45 minutes twice daily after meals …
Phase: NA • Sponsor: University of Michigan • Aim: Symptom relief
Last updated Aug 15, 2026 00:00 UTC
-
Can your own fat help heal scars?
Symptom relief CompletedThis study tests whether a single injection of nanofat—made from a person's own fat—can improve the appearance of atrophic scars caused by burns or trauma. Each participant has two similar scars: one gets the nanofat injection plus silicone gel, and the other gets only silicone g…
Phase: NA • Sponsor: Benha University • Aim: Symptom relief
Last updated Aug 15, 2026 00:00 UTC
-
Which nerve block eases lung surgery pain better? new study compares two options
Symptom relief CompletedThis study compared two types of nerve blocks (serratus anterior plane block and serratus posterior superior intercostal plane block) for pain after video-assisted lung surgery. 60 adults aged 18-65 were enrolled. Researchers measured pain levels and patient satisfaction to see w…
Phase: NA • Sponsor: Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital • Aim: Symptom relief
Last updated Aug 14, 2026 00:00 UTC
-
Can a gentle cream outperform harsh acne drugs?
Symptom relief CompletedThis study evaluates a new dermocosmetic cream containing 15% azelaic acid in people with mild-to-moderate acne. Researchers will observe how well the cream reduces acne lesions and improves skin discoloration, and how well it is tolerated, compared to standard treatments like or…
Sponsor: ISISPHARMA • Aim: Symptom relief
Last updated Aug 14, 2026 00:00 UTC
-
New cream offers hope for unbearable itch
Symptom relief CompletedThis Phase 3 trial tested a cream containing ruxolitinib in 204 adults with prurigo nodularis, a skin condition causing intense itching and hard bumps. Participants applied the cream twice daily for 12 weeks. The main goal was to see if it reduced itch by at least 4 points on a 0…
Phase: PHASE3 • Sponsor: Incyte Corporation • Aim: Symptom relief
Last updated Aug 14, 2026 00:00 UTC
-
New scalp cream aims to soothe dandruff and itch
Symptom relief CompletedThis study tests a special scalp cream to see if it safely relieves symptoms like flaking and itching in people with mild to moderate seborrheic dermatitis (a common dandruff condition). About 34 adults will use either the cream or a placebo for a set time. Researchers will measu…
Phase: NA • Sponsor: NovoBliss Research Pvt Ltd • Aim: Symptom relief
Last updated Aug 12, 2026 00:00 UTC
-
Can mushroom extracts soothe skin during breast radiation?
Symptom relief CompletedThis trial tests whether a cream made with mushroom extracts can help protect the skin of women undergoing radiation therapy for breast cancer. Participants use the cream or a standard moisturizer on the treated breast twice daily, starting before radiation and continuing for a m…
Phase: NA • Sponsor: Hifas da Terra S.L. • Aim: Symptom relief
Last updated Aug 12, 2026 00:00 UTC
-
Can a Bio-Natural cream calm Eczema's itch and flare?
Symptom relief CompletedThis trial is testing whether a bio-natural moisturizing cream, called SaaTwae, can safely ease symptoms of mild-to-moderate atopic dermatitis (eczema) in children and adults. Participants will apply the cream or a placebo to affected skin twice daily, and researchers will track …
Phase: NA • Sponsor: NovoBliss Research Pvt Ltd • Aim: Symptom relief
Last updated Aug 12, 2026 00:00 UTC
-
A new serum aims to clear acne and boost skin confidence
Symptom relief CompletedThis trial tests a topical serum containing 0.5% salicylic acid in adults with acne-prone skin. Over eight weeks, participants apply the serum as directed and report changes in acne symptoms, skin texture, tone, and more. The study uses questionnaires and expert photo grading to …
Phase: NA • Sponsor: Parea INC dba Cool as a Cucumber • Aim: Symptom relief
Last updated Aug 09, 2026 00:00 UTC
-
Firazyr tested in kids with rare swelling disorder
Symptom relief CompletedThis study in Japan looked at 32 children (ages 2 to under 18) with hereditary angioedema who received Firazyr injections for acute attacks. Researchers tracked side effects and how quickly symptoms resolved over 3 months. The goal was to gather real-world safety and effectivenes…
Sponsor: Takeda • Aim: Symptom relief
Last updated Aug 09, 2026 00:00 UTC
-
Fizzy drink aimed at erasing dark spots put to the test
Symptom relief CompletedThis study tests whether a daily fizzy drink containing glutathione can safely lighten facial dark spots and improve skin radiance. Sixty adults with hyperpigmentation will take either the active drink or a placebo for several weeks. Researchers will measure changes in pigmentati…
Phase: NA • Sponsor: NovoBliss Research Pvt Ltd • Aim: Symptom relief
Last updated Aug 08, 2026 00:03 UTC
-
Can glutathione boost gum lightening? a Split-Mouth trial investigates
Symptom relief CompletedThis trial tests whether adding a glutathione gel to microneedling improves the lightening of dark gums compared to microneedling alone. Fifteen healthy adults with gum pigmentation will receive both treatments on different sides of their mouth to compare results. The study measu…
Phase: NA • Sponsor: Krishnadevaraya College of Dental Sciences & Hospital • Aim: Symptom relief
Last updated Aug 07, 2026 00:00 UTC
-
New hope for kids with rare swelling disorder: sebetralstat shows promise
Symptom relief CompletedThis study tested a drug called sebetralstat in 36 children aged 2 to 11 with hereditary angioedema (HAE) types I or II, a condition that causes sudden, painful swelling. The goal was to see if the drug is safe and how well it works to relieve attacks. The trial was open-label, m…
Phase: PHASE3 • Sponsor: KalVista Pharmaceuticals, Ltd. • Aim: Symptom relief
Last updated Aug 07, 2026 00:00 UTC
-
New moisturizer shows promise for Acne-Prone skin in small study
Symptom relief CompletedThis study tested a facial moisturizer in 47 people with mild to moderate acne over 4 weeks. Researchers checked skin dryness, redness, and overall appearance, and participants reported how their skin felt. The goal was to see if the moisturizer is gentle and helpful for acne-pro…
Phase: NA • Sponsor: Kenvue Brands LLC • Aim: Symptom relief
Last updated Aug 05, 2026 00:00 UTC
-
Can a Skin-Repairing cream soothe eczema?
Symptom relief CompletedThis trial tests whether a cream containing hyaluronic acid, peptides, and plant extracts can improve skin barrier function and ease symptoms in people with atopic dermatitis (eczema). Participants, aged 2 and older, will use the cream alongside their usual topical corticosteroid…
Phase: NA • Sponsor: Instituto de Investigacion Biotecnologica, Farmaceutica y Medicamentos Huerfanos, S.L. • Aim: Symptom relief
Last updated Aug 05, 2026 00:00 UTC
-
Which laser tames 'Chicken Skin'? a Head-to-Head test
Symptom relief CompletedThis trial compares two types of lasers—fractional carbon dioxide and long-pulsed Nd:YAG—to see which works better for keratosis pilaris, the rough bumps often called 'chicken skin.' People aged 13 and older with keratosis pilaris on both upper arms will receive each laser on a d…
Phase: NA • Sponsor: Jose R. Reyes Memorial Medical Center • Aim: Symptom relief
Last updated Aug 02, 2026 00:00 UTC
-
Can a daily pill douse the Sun's pain for people with EPP?
Symptom relief CompletedThis phase 2a trial tests whether an experimental oral drug called PORT-77 can lower levels of protoporphyrin IX (PPIX) in the blood of adults with erythropoietic protoporphyria (EPP). People with EPP experience severe pain and skin reactions after even brief sun exposure. The st…
Phase: PHASE2 • Sponsor: Portal Therapeutics, Inc. • Aim: Symptom relief
Last updated Jul 31, 2026 00:00 UTC
-
New tablet shows promise for chronic hives in small study
Symptom relief CompletedThis study tested a daily tablet called NatureU Histra Disslove in 19 adults with chronic hives. Participants took one tablet before a main meal for 28 days. The study measured how well the tablet controlled hives, reduced symptoms, and improved quality of life. Results showed ch…
Phase: NA • Sponsor: OmniSolutions Laboratory Holdings Limited • Aim: Symptom relief
Last updated Jul 30, 2026 00:00 UTC
-
Green tea compound EGCG put to the test for clearer, more hydrated skin
Symptom relief CompletedThis large-scale trial is testing whether a topical cream containing epigallocatechin gallate (EGCG), a compound from green tea, can reduce facial redness (erythema), dark spots (melanin), and improve skin moisture. Over 300 participants will apply the cream twice daily for 84 da…
Phase: PHASE2, PHASE3 • Sponsor: Naniek Widyaningrum • Aim: Symptom relief
Last updated Jul 29, 2026 00:00 UTC
-
New laser zaps painful skin bumps in small trial
Symptom relief CompletedThis study tests whether a special 1726nm laser can safely reduce the painful bumps and inflammation caused by hidradenitis suppurativa (HS). Eight adults with mild to moderate HS will receive laser treatment on affected areas like armpits or groin. The main goal is to see if at …
Phase: NA • Sponsor: University of Miami • Aim: Symptom relief
Last updated Jul 29, 2026 00:00 UTC
-
Skip the clinic: could a smartphone survey replace your post-surgery eye check?
Symptom relief CompletedThis trial tests whether a telemedicine follow-up — a simple online survey with photos and a vision check — can safely replace the first in-person visit after low-risk eyelid procedures like droopy eyelid repair or skin cancer removal. Adults undergoing these surgeries will eithe…
Phase: NA • Sponsor: University of California, San Francisco • Aim: Symptom relief
Last updated Jul 26, 2026 00:00 UTC
-
A skin biostimulator aims to reverse sun damage without the peel downtime
Symptom relief CompletedThis trial tests whether a topical chemical skin biostimulator containing homocysteic acid can improve firmness, wrinkles, texture, and hydration in women aged 39–69 with sun-damaged skin. Twenty-five women receive four treatment sessions two weeks apart, followed by a home-care …
Phase: NA • Sponsor: Medical University of Silesia • Aim: Symptom relief
Last updated Jul 25, 2026 00:00 UTC
-
New drug offers hope for rosacea sufferers with burning pain
Symptom relief CompletedThis study looks at whether Cligabalin (HSK16149) can help people with a type of rosacea that causes severe burning and tingling on the face. It includes 60 adults whose redness and discomfort did not improve with standard treatments. The main goal is to see if the drug reduces f…
Phase: NA • Sponsor: The First Affiliated Hospital with Nanjing Medical University • Aim: Symptom relief
Last updated Jul 23, 2026 00:00 UTC
-
Could a daily powder boost skin elasticity and fight fatigue?
Symptom relief CompletedThis study tests whether a daily supplement called NPQ Plus can improve skin health, antioxidant status, fatigue, and well-being in healthy adults with minor skin concerns like dryness or itchiness. The supplement contains polyphenols, NMN, PQQ, CoQ10, and minerals. Participants …
Phase: NA • Sponsor: N REMEDIER (M) SDN BHD • Aim: Symptom relief
Last updated Jul 16, 2026 00:00 UTC
-
Light therapy vs. steroids: which saves your taste buds?
Symptom relief CompletedThis study looked at two treatments for oral lichen planus, a chronic mouth condition that can cause pain and change how food tastes. Researchers compared a light-based treatment (photodynamic therapy) with steroid cream in 65 adults. They measured taste ability, pain, and lesion…
Phase: NA • Sponsor: Medical University of Bialystok • Aim: Symptom relief
Last updated Jul 16, 2026 00:00 UTC
-
Sip your way to firmer skin? new study tests collagen drinks
Symptom relief CompletedThis study is testing whether drinking a collagen supplement every day for 4 weeks can improve skin firmness, elasticity, and collagen density. About 99 healthy Chinese adults with wrinkles and sagging skin will take part. Researchers will use special imaging and skin suction dev…
Phase: NA • Sponsor: TCI Co., Ltd. • Aim: Symptom relief
Last updated Jul 12, 2026 00:00 UTC
-
New injection aims to smooth cellulite dimples
Symptom relief CompletedThis study tests an investigational drug called CBL-514, given as an injection into areas of cellulite on the thighs. The goal is to see if it can safely reduce the severity of cellulite dimpling. The trial involves women aged 18 to 64 with mild to moderate cellulite. Researchers…
Phase: PHASE2 • Sponsor: Caliway Biopharmaceuticals Co., Ltd. • Aim: Symptom relief
Last updated Jul 11, 2026 00:00 UTC
-
Volleyball players may spike harder with myofascial release, study suggests
Symptom relief CompletedThis trial tests whether myofascial release techniques—a form of self-massage using rolling tools—can improve shoulder and elbow mobility, strength, and performance in volleyball players. Over eight weeks, participants perform the techniques three times per week with a physiother…
Phase: NA • Sponsor: Dokuz Eylul University • Aim: Symptom relief
Last updated Jul 09, 2026 00:00 UTC
-
New eczema ointment takes first step in human safety trial
Symptom relief CompletedThis early-stage trial tests whether HL-300 ointment is safe and tolerable when applied to the skin of healthy adult volunteers. Researchers will give single or multiple doses of the ointment or a placebo to 36 participants aged 18 to 45 in China. The study monitors for side effe…
Phase: PHASE1 • Sponsor: Hangzhou Highlightll Pharmaceutical Co., Ltd • Aim: Symptom relief
Last updated Jul 08, 2026 00:00 UTC
-
Shampoo that soothes the scalp may also help you sleep better
Symptom relief CompletedThis pilot study investigates whether using Nizoral® Daily Prevent shampoo and conditioner at least three times a week for two weeks can improve scalp comfort, sleep quality, and mood in adults who have both scalp discomfort and trouble sleeping. Participants wore a wrist sleep t…
Sponsor: Zentrela Inc. • Aim: Symptom relief
Last updated Jul 08, 2026 00:00 UTC
-
New cream and app aim to ease radiation burns for cancer patients
Symptom relief CompletedThis pilot study tests whether a special cream (KeraStat) and a mobile app (MyCap) can help manage skin rashes caused by radiation therapy in head and neck cancer patients. Sixteen participants will apply the cream at least twice daily during radiation and use the app to report t…
Phase: NA • Sponsor: Wake Forest University Health Sciences • Aim: Symptom relief
Last updated Jul 08, 2026 00:00 UTC
-
Which numbing cream eases laser pain best? new study puts two top contenders to the test
Symptom relief CompletedThis study tests two different numbing creams—one with lidocaine/prilocaine and another with lidocaine/tetracaine—against a placebo to see which works best for pain during Q-switched 532nm laser treatment for age spots (lentigines) and skin rejuvenation. Women aged 25 to 65 with …
Phase: EARLY_PHASE1 • Sponsor: Northwestern University • Aim: Symptom relief
Last updated Jul 03, 2026 00:00 UTC
-
Could a gel injection smooth away cellulite? new trial investigates
Symptom relief CompletedThis study tests whether ALIDYA, a gel injected into the skin, can improve the appearance of cellulite on the back of the thighs. Thirty women aged 20 to 45 with mild to moderate cellulite received six weekly treatments. Researchers used photos, ultrasound, and other imaging to m…
Phase: NA • Sponsor: Medical University of Silesia • Aim: Symptom relief
Last updated Jul 02, 2026 00:00 UTC
-
Can an amino acid supplement calm childhood eczema?
Symptom relief CompletedThis study tested whether a supplement containing L-histidine, along with a topical oil or lotion and unscented soap, could improve mild-to-moderate eczema in children. Forty children ages 1 to 12 were split into two groups: one received a powder supplement and the other a gummy …
Phase: NA • Sponsor: Codex Labs Corporation • Aim: Symptom relief
Last updated Jun 28, 2026 00:00 UTC
-
New pain drug may cut Post-Surgery nausea
Symptom relief CompletedThis study compared two painkillers, oliceridine and morphine, in 252 adults undergoing laparoscopic colorectal surgery. The goal was to see if oliceridine causes less nausea and vomiting after surgery. Patients used a pump to control their pain medicine for up to 3 days after th…
Phase: PHASE4 • Sponsor: Peking University First Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 14:02 UTC
-
Smartphone app aims to ease bed sore care for homebound patients
Symptom relief CompletedThis study tested whether a mobile application could help nurses and caregivers better manage pressure injuries (bedsores) in people receiving home care. Thirty participants were followed for 28 days, with caregivers using the app to track wound healing and receive reminders. The…
Phase: NA • Sponsor: Fenerbahce University • Aim: Symptom relief
Last updated Jun 27, 2026 14:01 UTC
-
Fish oil supplements show promise for stubborn leg ulcers
Symptom relief CompletedThis study tested whether taking fish oil supplements (EPA and DHA) could help heal chronic venous leg ulcers in adults aged 55 and older. The idea was that fish oil might reduce inflammation at the wound site, allowing the ulcer to heal. Researchers measured changes in blood mar…
Phase: NA • Sponsor: Ohio State University • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Green tea cream shows promise for rare 'Fish Scale' skin disease
Symptom relief CompletedThis study tested a cream made from green tea extract (Veregen) on 6 people with lamellar ichthyosis, a rare genetic condition that causes severe dry, scaly skin. Participants applied the cream to one side of their body and a standard moisturizer to the other for 4 weeks. The goa…
Phase: PHASE3 • Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
App eases psoriasis burden in landmark trial
Symptom relief CompletedThis study tested a self-guided online program for people with psoriasis. 348 adults were split into two groups: one got the app plus their regular treatment, the other got regular treatment alone. The main goal was to see if the app improved quality of life over 12 months.
Phase: NA • Sponsor: Gaia AG • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
New study tests best way to position ARDS patients to avoid bedsores
Symptom relief CompletedThis study tested two ways of positioning patients with severe lung injury (ARDS) who are on ventilators and placed face-down (prone) to help breathing. The goal was to see if a 'swimmer' position—where the head is turned and one arm is bent—causes fewer severe pressure sores tha…
Phase: NA • Sponsor: University Hospital, Tours • Aim: Symptom relief
Last updated Jun 27, 2026 13:07 UTC
-
New serums take on hydroquinone in skin brightening showdown
Symptom relief CompletedThis 4-week pilot study tested two brightening serums against 4% hydroquinone in 18 adults with hyperpigmentation or melasma. Each participant used different products on each side of their face to compare results. The goal was to see if the serums could improve skin tone evenness…
Phase: NA • Sponsor: Revision Skincare • Aim: Symptom relief
Last updated Jun 27, 2026 13:06 UTC
-
Spray vs. ointment: which works better for incontinence rash?
Symptom relief CompletedThis study tested whether a silicone barrier spray works as well as a standard zinc oxide ointment for treating mild skin rash caused by incontinence in nursing home residents. Forty participants received one of the two treatments as part of a regular skin care routine. Researche…
Phase: NA • Sponsor: Taoyuan Armed Forces General Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 13:05 UTC
-
Simple skin care may shield kids from cancer drug side effects
Symptom relief CompletedThis study tested a preventive skin care routine in 14 children (ages 6 months to 18 years) with brain tumors who were receiving targeted therapy (BRAF, MEK, or Pan-RAF inhibitors). The goal was to see if gentle skin care and sun protection could reduce or prevent skin reactions …
Phase: PHASE2 • Sponsor: Dana-Farber Cancer Institute • Aim: Symptom relief
Last updated Jun 27, 2026 13:05 UTC
-
Could a simple skincare routine soothe psoriasis Flare-Ups?
Symptom relief CompletedThis study tests whether a daily skincare routine using Cetaphil cleansers and moisturizers can improve skin symptoms and quality of life for people with mild-to-severe plaque psoriasis. Participants apply the products to one side of their body while continuing their usual prescr…
Phase: PHASE4 • Sponsor: Galderma R&D • Aim: Symptom relief
Last updated Jun 27, 2026 13:05 UTC
-
Easing the squeeze: new study aims to reduce ear pain in oxygen chambers
Symptom relief CompletedThis study tested whether changing how fast pressure increases during hyperbaric oxygen therapy (HBOT) can lower the chance of ear pain and injury. Over 1,500 people receiving HBOT were randomly assigned to one of two compression schedules. The goal was to see if a non-linear (sl…
Phase: NA • Sponsor: Northwell Health • Aim: Symptom relief
Last updated Jun 27, 2026 13:05 UTC
-
New method aims to make compression stockings easier to wear
Symptom relief CompletedThis study tested a new, standardized process for providing assistive devices (like special tools) to help people put on and take off compression stockings. 220 adults who need these stockings long-term took part. The goal was to see if the new method improves how often people us…
Phase: NA • Sponsor: Zuyd University of Applied Sciences • Aim: Symptom relief
Last updated Jun 27, 2026 13:04 UTC
-
New brightening peel shows promise for sun spots and uneven skin tone
Symptom relief CompletedThis completed study tested a brightening treatment (a type of chemical peel) combined with a retinol serum and post-procedure cream on 11 healthy women aged 20 to 65 with moderate facial pigmentation from sun exposure or blemishes. Participants received four treatment sessions t…
Phase: NA • Sponsor: Revision Skincare • Aim: Symptom relief
Last updated Jun 27, 2026 13:03 UTC
-
Can a blood vessel drug ease Raynaud's in scleroderma?
Symptom relief CompletedThis Phase 2 trial tested whether selexipag, a drug that opens blood vessels, can reduce the number of Raynaud's attacks in adults with systemic sclerosis. 74 participants took either selexipag or a placebo twice daily. The main goal was to see if the drug lowered weekly attack f…
Phase: PHASE2 • Sponsor: Actelion • Aim: Symptom relief
Last updated Jun 27, 2026 13:01 UTC
-
New dissolvable implant shows promise for smoothing wrinkles
Symptom relief CompletedThis study tested a medical device called ULTRACOL, a dissolvable implant placed under the skin, to see if it can safely improve wrinkles and other skin contour problems. 23 adults with facial wrinkles or skin aging took part. The main goal was to measure changes in wrinkle sever…
Phase: NA • Sponsor: Estelab Clinic • Aim: Symptom relief
Last updated Jun 27, 2026 13:01 UTC
-
New gel filler shows promise for wrinkle reduction
Symptom relief CompletedThis study tested a gel-like implant (Algeness) to improve the look of wrinkles and other skin contour problems. 40 adults aged 30-65 with age-related skin changes took part. The main goal was to see if the implant reduced wrinkle severity on a standard scale. The study is comple…
Phase: NA • Sponsor: Estelab Clinic • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
New injection shows promise for relieving intense itching
Symptom relief CompletedThis Phase 3 trial tests whether Stapokibart injection can reduce severe itching and skin bumps in adults with prurigo nodularis. About 200 participants will receive either the drug or a placebo for 24 weeks. The main goal is to see if itching improves by at least 4 points on a 0…
Phase: PHASE3 • Sponsor: Keymed Biosciences Co.Ltd • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
New shot targets cellulite: small study tests qwo on butt and thighs
Symptom relief CompletedThis completed Phase 4 study tested multiple doses of Qwo, a drug made from bacterial enzymes, for treating mild to moderate cellulite in adult women. Five participants received injections in their buttocks and thighs over three sessions. The goal was to see if the treatment impr…
Phase: PHASE4 • Sponsor: DMR Research, PLLC • Aim: Symptom relief
Last updated Jun 27, 2026 12:38 UTC
-
Can muscle feedback or electrical stimulation help kids move better after brain tumor surgery?
Symptom relief CompletedThis study compared two therapies—myofeedback and neuromuscular electrical stimulation—to see which better improves arm and hand function in children aged 6 to 14 who have one-sided weakness (hemiplegia) after brain tumor surgery. Forty-five children participated, and researchers…
Phase: NA • Sponsor: Cairo University • Aim: Symptom relief
Last updated Jun 27, 2026 12:38 UTC
-
DIY bandage change: could self-dressing heal foot ulcers just as well?
Symptom relief CompletedThis study tested whether people with diabetic foot ulcers can safely change their own dressings compared to having a nurse do it. Sixty adults with mild to moderate ulcers were randomly assigned to either self-dressing or nurse-led dressing. The researchers tracked healing time,…
Phase: NA • Sponsor: Ain Shams University • Aim: Symptom relief
Last updated Jun 27, 2026 12:37 UTC
-
New ointment shows promise for rare skin scaling disease
Symptom relief CompletedThis study tested two strengths of a topical isotretinoin ointment (TMB-001) in 34 people aged 9 and older with congenital ichthyosis, a rare genetic skin condition causing severe scaling. The main goal was to see if the ointment could reduce scaling by at least 50% compared to a…
Phase: PHASE2 • Sponsor: LEO Pharma • Aim: Symptom relief
Last updated Jun 27, 2026 12:36 UTC
-
Migraine drug shows promise for IBS belly pain in small study
Symptom relief CompletedThis pilot study tested whether rimegepant (Nurtec), a drug used for migraines, can reduce chronic abdominal pain in people with irritable bowel syndrome (IBS). Thirty-nine adults with non-constipation IBS took either the drug or a placebo for 28 days. Researchers measured change…
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated Jun 27, 2026 12:36 UTC
-
Laser vs. IPL: which zaps red scars best?
Symptom relief CompletedThis study tested two light-based treatments—long-pulsed ND:YAG laser and intense pulsed light (IPL)—on red scars from injuries or surgery. Forty people with scars on the head or neck received four sessions, one month apart. The goal was to see which treatment reduces redness mor…
Phase: NA • Sponsor: Alexandria University • Aim: Symptom relief
Last updated Jun 27, 2026 12:35 UTC
-
Talking it out: group therapy may ease eczema symptoms
Symptom relief CompletedThis pilot study tested whether adding group psychotherapy to standard care can help adults with moderate-to-severe atopic dermatitis (eczema). Thirty-two participants were assigned to either standard care alone, standard care plus stress management and resilience training, or st…
Phase: NA • Sponsor: Semmelweis University • Aim: Symptom relief
Last updated Jun 27, 2026 12:35 UTC
-
Blue dye and red light: a new hope for itchy skin?
Symptom relief CompletedThis pilot study tested whether applying methylene blue (a dye) to skin lesions and then shining red light on them could improve skin roughness in people with lichen amyloidosis, a condition causing itchy, bumpy patches. Fifteen Asian adults with the condition received the treatm…
Phase: NA • Sponsor: Chulalongkorn University • Aim: Symptom relief
Last updated Jun 27, 2026 12:34 UTC
-
Could a UV laser smooth out this rare skin condition?
Symptom relief CompletedThis pilot study tested a 308-nm excimer laser on 15 Asian adults with lichen amyloidosis, a condition that causes itchy, rough patches on the skin. The goal was to see if the laser could improve skin roughness. The study is small and early, so results are not conclusive.
Phase: NA • Sponsor: Chulalongkorn University • Aim: Symptom relief
Last updated Jun 27, 2026 12:33 UTC
-
Could a common eye drop gel speed up wound healing?
Symptom relief CompletedThis study tested whether applying timolol gel (a drug usually used for glaucoma) to small surgical wounds after skin cancer removal helps them heal faster and look better. Researchers compared timolol gel to plain Vaseline in 87 adults with wounds up to 1.5 cm. The main goal was…
Phase: PHASE2, PHASE3 • Sponsor: Brigham and Women's Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:33 UTC
-
New laser shows promise for wrinkle reduction in clinical trial
Symptom relief CompletedThis study tested a laser device (NIRA Laser M2.1) on 120 adults aged 35 and older to see if it could safely reduce full-face wrinkles. Some participants also used a topical cream after the laser. Wrinkle improvement was judged by experts looking at before-and-after photos, and p…
Phase: NA • Sponsor: NIRA Innovations Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 12:31 UTC
-
Gentle neck moves may ease tennis Players' pain
Symptom relief CompletedThis study tested whether adding gentle spinal mobilization to a home exercise program could reduce neck pain and improve fitness in recreational tennis players. Thirty adults with mechanical neck pain were split into two groups: one did only home exercises for three weeks, and t…
Phase: NA • Sponsor: Istinye University • Aim: Symptom relief
Last updated Jun 27, 2026 12:31 UTC
-
Tennis players get back in the game: spinal mobilization may reduce pain
Symptom relief CompletedThis study looked at whether adding spinal mobilization (a type of hands-on therapy) to a home exercise program helps recreational tennis players with mechanical low back pain. Thirty-one players aged 18-45 were split into two groups: one did only home exercises for 3 weeks, and …
Phase: NA • Sponsor: Istinye University • Aim: Symptom relief
Last updated Jun 27, 2026 12:31 UTC
-
Vitamin K2 shows promise for childhood eczema
Symptom relief CompletedThis study looked at whether adding vitamin K2 to standard treatment could improve symptoms in children aged 6–12 with moderate-to-severe atopic dermatitis (eczema). For 12 weeks, 100 children received either vitamin K2 or a placebo alongside their usual care. The main goal was t…
Phase: NA • Sponsor: October 6 University • Aim: Symptom relief
Last updated Jun 27, 2026 12:31 UTC
-
Fun and fitness: VR games may boost Kids' activity levels
Symptom relief CompletedThis study looked at whether aerobic exercise and virtual reality games could improve functional capacity, activity, and participation in children aged 6-10 living in care facilities. Sixty-three children were split into groups: one did aerobic exercise, one played VR games, and …
Phase: NA • Sponsor: Hasan Kalyoncu University • Aim: Symptom relief
Last updated Jun 27, 2026 12:30 UTC
-
New shampoo takes on dandruff in Head-to-Head trial
Symptom relief CompletedThis study tested whether a cosmetic shampoo can reduce dandruff and scalp flaking in adults with mild to moderate seborrheic dermatitis. 90 participants used the test shampoo, a standard medicated shampoo, or a regular cosmetic shampoo for 4 weeks. Researchers measured dandruff …
Phase: NA • Sponsor: Pierre Fabre Dermo Cosmetique • Aim: Symptom relief
Last updated Jun 27, 2026 12:30 UTC
-
Cancer drug repurposed to fight rare skin disease in small safety trial
Symptom relief CompletedThis early-phase study tested whether a drug used for lymphoma, brentuximab vedotin, is safe for people with a severe form of scleroderma (diffuse cutaneous systemic sclerosis). The drug targets overactive immune cells that may drive the disease. Only 17 people took part, and the…
Phase: PHASE1, PHASE2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
Can a simple cream soothe psoriasis itch? small trial hopes to find out
Symptom relief CompletedThis completed study tested a moisturizing medical device called RL3020-DP0364 (Dexeryl) in 40 adults with stable mild plaque psoriasis, dry skin, and itching. Participants applied the cream to their whole body (except head) for about a month. The main goal was to see if it reduc…
Phase: NA • Sponsor: Pierre Fabre Dermo Cosmetique • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
New ozonated hair cream cuts scalp oil by 28% in women
Symptom relief CompletedThis study tested a special cream made with ozonated oils and biotin for women with oily scalp. 66 women aged 18-40 used the cream or a placebo every night for 6 weeks. The active cream reduced scalp oil by 28%, compared to 10% for placebo, and was well-tolerated with only mild i…
Phase: NA • Sponsor: Chadi Khatib • Aim: Symptom relief
Last updated Jun 27, 2026 12:26 UTC
-
New device AVELI tackles cellulite and fibrosis in liposuction patients
Symptom relief CompletedThis study tested a device called AVELI to safely reduce cellulite and fibrous tissue in 130 people undergoing body contouring surgery. Researchers measured safety, patient satisfaction, and appearance improvements over 9 months. The goal was to see if adding AVELI to standard li…
Phase: NA • Sponsor: Total Definer Research Group • Aim: Symptom relief
Last updated Jun 27, 2026 12:25 UTC
-
Tapping away fear: EFT shows promise for melanoma remission patients
Symptom relief CompletedThis study tested Emotional Freedom Techniques (EFT), a therapy that combines talking with gentle tapping on acupressure points, in 56 people who had been treated for melanoma and were in remission. The goal was to see if EFT could reduce fear of the cancer coming back and improv…
Phase: NA • Sponsor: Soul Medicine Institute • Aim: Symptom relief
Last updated Jun 27, 2026 12:24 UTC
-
Supplements and exercise show promise for kids with muscle disease
Symptom relief CompletedThis study looked at whether taking creatine and coenzyme Q10 supplements, along with exercise, could help children with juvenile myositis (a disease that causes muscle weakness and fatigue). Fifteen children aged 7 to 18 took part. The goal was to see if these supplements could …
Phase: NA • Sponsor: The Hospital for Sick Children • Aim: Symptom relief
Last updated Jun 27, 2026 12:24 UTC
-
New silicone dressings show promise for chronic leg ulcers
Symptom relief CompletedThis study looked at whether two silicone dressings (RespoSorb Silicone and RespoSorb Silicone Border) help heal long-lasting leg and foot wounds. 80 adults with venous leg ulcers or diabetic foot ulcers took part. The main goal was to see if the dressings reduce wound size, and …
Phase: NA • Sponsor: HARTMANN GROUP • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
New light device aims to ease pain of skin spot treatment
Symptom relief CompletedThis study tested a new device called Flexitheralight against the usual light therapy for actinic keratosis, which are rough spots caused by sun damage. About 29 adults with at least 10 spots on their forehead or scalp took part. The goal was to see if the new device works just a…
Phase: NA • Sponsor: University Hospital, Lille • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
Psoriasis cream showdown: new formula vs. approved treatment
Symptom relief CompletedThis study compared a new tapinarof cream to an already-approved one (Vtama®) for treating plaque psoriasis, a skin condition causing red, scaly patches. 575 adults with mild to moderate psoriasis used one of the creams or a placebo for a set time. The goal was to see if the new …
Phase: PHASE1 • Sponsor: Sun Pharmaceutical Industries, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
New light device eases mouth pain in lichen planus
Symptom relief CompletedThis study tested a home-use light device and special mouth rinse to help people with oral lichen planus, a painful mouth condition. Thirteen participants used the device daily for a year alongside standard care. The goal was to see if it could reduce pain and inflammation better…
Phase: NA • Sponsor: Koite Health Oy • Aim: Symptom relief
Last updated Jun 27, 2026 12:08 UTC
-
Could an antidepressant ease cancer treatment pain? new study investigates
Symptom relief CompletedThis phase 2 trial tested whether adding venlafaxine (an antidepressant) to a standard pain regimen of gabapentin, methadone, and oxycodone could better control pain in 62 people with head and neck cancer undergoing chemoradiation. The study measured pain scores and side effects …
Phase: PHASE2 • Sponsor: Roswell Park Cancer Institute • Aim: Symptom relief
Last updated Jun 27, 2026 12:08 UTC
-
New laser combo eases tight mouths in rare skin disease
Symptom relief CompletedThis small study tested a new way to treat microstomia (a tight, small mouth) caused by scleroderma. Three adults received three sessions of a laser treatment that delivered hyaluronidase, an enzyme that breaks down tight tissue, directly into the skin. The goal was to improve mo…
Phase: EARLY_PHASE1 • Sponsor: University of Nebraska • Aim: Symptom relief
Last updated Jun 27, 2026 12:07 UTC
-
New eczema cream shows promise in early trial
Symptom relief CompletedThis Phase 2 trial tested a cream called VC005 on 118 adults with mild to moderate atopic dermatitis (eczema). The study compared the cream to a placebo to see if it safely reduces eczema symptoms like itching and skin redness. Results will help decide if larger studies are warra…
Phase: PHASE2 • Sponsor: Jiangsu vcare pharmaceutical technology co., LTD • Aim: Symptom relief
Last updated Jun 27, 2026 12:07 UTC
-
New eczema pill shows promise in late-stage trial
Symptom relief CompletedThis study tested an experimental oral drug called LNK01001 against a placebo in 356 adults with moderate to severe atopic dermatitis (eczema) who had not responded well to creams or other treatments. The goal was to see if the drug could improve skin clearing and reduce itching …
Phase: PHASE3 • Sponsor: Lynk Pharmaceuticals Co., Ltd • Aim: Symptom relief
Last updated Jun 27, 2026 12:06 UTC
-
Could a butyrate cream soothe eczema in kids without steroids?
Symptom relief CompletedThis study tested a special cream containing a butyrate releaser (a substance that helps the skin barrier) in 100 children aged 6-36 months with eczema. The cream was compared to a standard moisturizer over 12 weeks. The goal was to see if it could reduce eczema severity and impr…
Phase: NA • Sponsor: Federico II University • Aim: Symptom relief
Last updated Jun 27, 2026 12:06 UTC
-
New lotion for Kids' psoriasis under the microscope
Symptom relief CompletedThis study looked at how a prescription lotion (IDP-118) works in children aged 4 to 16 with moderate to severe plaque psoriasis. Researchers measured how much of the drug enters the bloodstream and whether it affects the body's stress hormone system (HPA axis). The goal was to c…
Phase: PHASE4 • Sponsor: Bausch Health Americas, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 12:06 UTC
-
Caffeine boosts weightlifting performance – but Don't expect miracles
Symptom relief CompletedThis study tested whether caffeine helps elite weightlifters perform better in competition. Fourteen athletes took either caffeine or a placebo before a simulated weightlifting meet. The results suggest caffeine can provide a small performance boost, but the effect is modest and …
Phase: NA • Sponsor: Universidad Pontificia Comillas • Aim: Symptom relief
Last updated Jun 27, 2026 12:05 UTC
-
Nano-Silver bandage promises quicker gum recovery after dark spot removal
Symptom relief CompletedThis study tested whether a nano-crystalline silver dressing helps gums heal faster and with less pain after surgical removal of dark gum pigmentation. Twelve adults with moderate to severe gum pigmentation had the surgery, and the silver dressing was compared to a standard dress…
Phase: NA • Sponsor: Damascus University • Aim: Symptom relief
Last updated Jun 27, 2026 12:05 UTC
-
Fasting for clearer skin? study tests Time-Restricted eating for psoriasis
Symptom relief CompletedThis study looked at whether intermittent fasting (eating only during certain hours) can reduce disease severity and improve quality of life for people with psoriasis and psoriatic arthritis. Sixty overweight adults were randomly assigned to either follow an intermittent fasting …
Phase: NA • Sponsor: Ohio State University • Aim: Symptom relief
Last updated Jun 27, 2026 12:05 UTC
-
Laser zaps face veins in scleroderma patients – 21 test it out
Symptom relief CompletedThis study tested a pulsed dye laser to reduce red veins (telangiectasias) on the face and neck in 21 people with scleroderma. Participants received four laser sessions, and the researchers checked how many veins disappeared, how patients felt about the results, and any side effe…
Phase: NA • Sponsor: University Hospital, Caen • Aim: Symptom relief
Last updated Jun 27, 2026 12:03 UTC
-
New ointment shows promise for eczema sufferers
Symptom relief CompletedThis study tested a new ointment called CGB-500, which contains the drug tofacitinib, for treating eczema (atopic dermatitis) in 180 people aged 12 and older. Participants applied the ointment or a placebo daily for 8 weeks. The goal was to see if it safely reduces skin redness, …
Phase: PHASE2 • Sponsor: CAGE Bio Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 12:03 UTC
-
Magnetism vs. warts: can a Healer's touch make them disappear?
Symptom relief CompletedThis study tests whether biofield therapy, a type of energy healing or magnetism, can make common warts on hands and feet disappear. Sixty-two adults with warts for at least 3 months will be randomly assigned to receive either real biofield therapy from a recognized healer or fak…
Phase: NA • Sponsor: University Hospital, Caen • Aim: Symptom relief
Last updated Jun 27, 2026 12:03 UTC
-
Massage your scar, heal your pelvis: new study tests simple postpartum fix
Symptom relief CompletedThis study looked at whether a larger trial on self-scar massage for women after childbirth is possible. 14 new mothers with healed episiotomy or perineal tears were asked to massage their scar tissue at home for 6 weeks. The goal was to see if women would stick with the routine …
Phase: NA • Sponsor: University of Calgary • Aim: Symptom relief
Last updated Jun 27, 2026 12:02 UTC
-
Which exercise focus works best for kids with rheumatic conditions?
Symptom relief CompletedThis study tested two different exercise programs in 28 children and teens with rheumatic diseases like juvenile arthritis and familial Mediterranean fever. One program used external focus (thinking about the movement's effect), the other used internal focus (thinking about the b…
Phase: NA • Sponsor: Istanbul University - Cerrahpasa • Aim: Symptom relief
Last updated Jun 27, 2026 12:01 UTC
-
New hope for nail psoriasis: tildrakizumab shows promise in trial
Symptom relief CompletedThis Phase 3 study tested the drug tildrakizumab in 99 adults with moderate to severe nail psoriasis. Participants received either the drug or a placebo for 28 weeks to see if it improved nail appearance and reduced pain. The trial is complete, and results may help determine if t…
Phase: PHASE3 • Sponsor: Sun Pharmaceutical Industries Limited • Aim: Symptom relief
Last updated Jun 27, 2026 12:01 UTC
-
New gel shows promise for rosacea Flare-Ups
Symptom relief CompletedThis study tested a topical gel called CGB-400 in 78 adults with moderate to severe rosacea. Participants applied the gel or a placebo twice daily for 12 weeks. Researchers counted inflammatory lesions and assessed skin clarity to see if the gel reduces symptoms.
Phase: PHASE2 • Sponsor: CAGE Bio Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 12:01 UTC
-
Cutting salt and sugar may tame steroid side effects
Symptom relief CompletedThis study looked at whether a diet low in salt and sugar can reduce common side effects of corticosteroid treatment, such as weight gain, high blood pressure, and diabetes. Fifty adults with autoimmune diseases or asthma who were starting high-dose corticosteroids were randomly …
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Symptom relief
Last updated Jun 27, 2026 12:01 UTC
-
Can an antioxidant boost light therapy for vitiligo?
Symptom relief CompletedThis study tested whether adding a special antioxidant pill (GLISODIN) to standard UVB light therapy helps treat vitiligo better than light therapy alone. Fifty adults with non-segmental vitiligo covering more than 5% of their body took part. The main goal was to see if the combi…
Phase: NA • Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Symptom relief
Last updated Jun 27, 2026 12:00 UTC
-
Mushroom cream soothes baby skin rashes in new study
Symptom relief CompletedThis study tested a cream paste containing pleuran (a beta-glucan from oyster mushrooms) on 110 children with diaper rash, perioral dermatitis, or neonatal pustulosis. Participants applied the cream 2-3 times daily for up to 2 weeks without other treatments. Researchers measured …
Phase: NA • Sponsor: Pleuran, s.r.o. • Aim: Symptom relief
Last updated Jun 27, 2026 12:00 UTC
-
New study examines pain and adherence in patients switching to concentrated adalimumab
Symptom relief CompletedThis study involved 324 adults with conditions like Crohn's disease, arthritis, or psoriasis who switched from a standard to a higher-concentration form of adalimumab (AVT-02). Researchers measured injection site pain and how well patients stuck with their treatment over 180 days…
Sponsor: Jamp Pharma Corporation • Aim: Symptom relief
Last updated Jun 27, 2026 11:02 UTC
-
New moisturizer shows promise for dandruff relief in small study
Symptom relief CompletedThis study tested a scalp moisturizer made with celastrol and chicory root extract in 23 adults with dry, flaky scalp or dandruff. Participants applied it every night for 4 weeks. Researchers used artificial intelligence to measure changes in scalp condition. The goal was to see …
Phase: NA • Sponsor: Seoul National University Bundang Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 11:00 UTC
-
Could a natural compound help clear acne and scars?
Symptom relief CompletedThis study tested whether a cream made from icariin, a plant compound, can improve acne and reduce acne scars. Twenty-five adults applied the cream or a control solution to their face twice daily for two months. The goal was to see if it lowers the number of pimples and scars and…
Phase: NA • Sponsor: Seoul National University Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 09:11 UTC
-
Psoriasis study probes hidden heart risks
Knowledge-focused CompletedThis completed study looked at 386 adults with psoriasis to understand how skin inflammation might be linked to heart and blood vessel diseases. Participants had up to seven visits over four years, including blood tests, heart scans, and optional skin biopsies. The goal was to se…
Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Knowledge-focused
Last updated Aug 18, 2026 05:00 UTC
-
Scientists dig into the mystery of unexplained allergic shock
Knowledge-focused CompletedThis study looks at people who have severe allergic reactions (anaphylaxis), especially when the cause is unknown. Researchers will do blood tests and bone marrow biopsies to find genetic or molecular clues. The goal is to understand what goes wrong in the body, not to test a new…
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Aug 18, 2026 05:00 UTC
-
High-Tech suits tested on cyclists – do they really work?
Knowledge-focused CompletedThis study tested whether full-body suits made with far-infrared (FIR) emitting fibers affect body temperature, heart rate, oxygen use, and power output in young competitive cyclists. Nine cyclists rode a stationary bike for 40 minutes at a steady pace, then did a 5-second sprint…
Phase: NA • Sponsor: University of Palermo • Aim: Knowledge-focused
Last updated Aug 18, 2026 05:00 UTC
-
Military myositis mystery: could exposures be the trigger?
Knowledge-focused CompletedThis study investigated whether environmental exposures during military service increase the risk of developing myositis, a rare autoimmune disease that attacks muscles. Researchers compared 37 military personnel with and without myositis using questionnaires and blood samples. N…
Sponsor: National Institute of Environmental Health Sciences (NIEHS) • Aim: Knowledge-focused
Last updated Aug 18, 2026 05:00 UTC
-
Scientists study rare DNA repair diseases to unlock cancer prevention secrets
Knowledge-focused CompletedThis study looked at people with three rare genetic conditions—xeroderma pigmentosum (XP), Cockayne syndrome (CS), and trichothiodystrophy (TTD)—that affect the body's ability to repair DNA. Researchers examined 709 participants to understand how these defects relate to cancer ri…
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Aug 18, 2026 05:00 UTC
-
NIH launches major study to unlock secrets of rare inflammatory diseases
Knowledge-focused CompletedThis study follows up to 5,000 people with autoinflammatory diseases (like NOMID, CANDLE, and juvenile dermatomyositis) and their healthy relatives. Researchers will collect medical history, blood samples, and imaging over 2-5 day visits to learn how these diseases work and find …
Sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) • Aim: Knowledge-focused
Last updated Aug 16, 2026 00:00 UTC
-
Healthy men needed to track Drug's path out of the body
Knowledge-focused CompletedThis early-stage study looks at how a drug called Flonoltinib maleate (being developed for a bone marrow condition) is processed and removed from the body. Six healthy adult men will take a single dose, and researchers will measure the drug and its breakdown products in blood, ur…
Phase: PHASE1 • Sponsor: Chengdu Zenitar Biomedical Technology Co., Ltd • Aim: Knowledge-focused
Last updated Aug 15, 2026 00:00 UTC
-
Gum disease clues: could hippo proteins be the missing link?
Knowledge-focused CompletedThis study investigates whether proteins from the Hippo signaling pathway—known to control cell growth and bone health—are present at different levels in the gum fluid of people with healthy gums, gingivitis, or periodontitis. Researchers will collect fluid samples from 75 partic…
Sponsor: Inonu University • Aim: Knowledge-focused
Last updated Aug 15, 2026 00:00 UTC
-
Twin study seeks clues to rheumatic disease mysteries
Knowledge-focused CompletedThis study looks at families where one sibling has a rheumatic disease (like rheumatoid arthritis or lupus) and the other does not. Researchers compare their blood, genes, and environmental exposures to find clues about why one got sick. Over 1,000 participants are involved, incl…
Sponsor: National Institute of Environmental Health Sciences (NIEHS) • Aim: Knowledge-focused
Last updated Aug 15, 2026 00:00 UTC
-
NIH study gathers skin samples to unlock secrets of skin diseases
Knowledge-focused CompletedThis study collected blood, skin, and mucosal samples from 304 healthy volunteers and patients with skin or systemic diseases. The samples were used to support basic science and clinical research at the NIH. Participants included people of all genders and racial/ethnic groups, an…
Sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) • Aim: Knowledge-focused
Last updated Aug 15, 2026 00:00 UTC
-
Anthrax secrets revealed: new study tracks infection and vaccine response
Knowledge-focused CompletedThis study follows people who have or had anthrax, those exposed, and healthy vaccinated volunteers to learn how the body fights the disease. Researchers will track symptoms, immune responses, and long-term health for up to 2 years. The goal is to better understand anthrax and im…
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Aug 14, 2026 00:00 UTC
-
E-Learning could sharpen Doctors' eye for skin cancer
Knowledge-focused CompletedThis trial tests whether an online training course, called MelaMEd, can improve primary care doctors' ability to detect and manage melanoma, the most serious form of skin cancer. Participants—general practitioners, trainees, and pediatricians—answer questions and review skin lesi…
Phase: NA • Sponsor: Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS • Aim: Knowledge-focused
Last updated Aug 13, 2026 00:00 UTC
-
Can acne drug harm the eyes? new study investigates
Knowledge-focused CompletedThis study looks at how oral isotretinoin, a common acne treatment, affects the surface of the eye and the meibomian glands, which produce the oily layer of tears. Researchers will measure tear film stability, gland structure, and dry eye symptoms in 60 acne patients before and a…
Phase: NA • Sponsor: Benha University • Aim: Knowledge-focused
Last updated Aug 12, 2026 00:00 UTC
-
Eczema Drug's impact on vaccines under microscope
Knowledge-focused CompletedThis study looked at how well vaccines work in adults with moderate-to-severe eczema who are taking amlitelimab, an experimental drug. About 224 participants received either amlitelimab or a placebo along with tetanus and pneumonia vaccines. The goal was to see if the drug change…
Phase: PHASE2 • Sponsor: Sanofi • Aim: Knowledge-focused
Last updated Aug 12, 2026 00:00 UTC
-
Gene hunt aims to unlock NF1's mysteries
Knowledge-focused CompletedThis study looks at people with neurofibromatosis type 1 (NF1) and their families to find out why some have more severe symptoms than others. Researchers will collect medical history, blood samples, and images to study genes and physical traits. The goal is to identify genes that…
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Aug 09, 2026 00:00 UTC
-
Scientists hunt for genetic and environmental triggers of rare muscle diseases
Knowledge-focused CompletedThis study looked at 719 people, including patients with autoimmune connective tissue diseases like myositis, their blood relatives, and healthy volunteers. Researchers collected blood samples and medical histories to find genetic and environmental factors that may trigger these …
Sponsor: National Institute of Environmental Health Sciences (NIEHS) • Aim: Knowledge-focused
Last updated Aug 09, 2026 00:00 UTC
-
Comic book teaches kids to beat pain fears
Knowledge-focused CompletedThis study tested a school program called SocLaLola that uses a comic book to teach children aged 8-11 about pain. The goal was to see if it improves kids' understanding of pain and reduces their fear of moving. Eighty-two students from two primary schools took part. The program …
Phase: NA • Sponsor: Universitat de Lleida • Aim: Knowledge-focused
Last updated Aug 07, 2026 00:00 UTC
-
Brain wave study tests eczema cream vs. water
Knowledge-focused CompletedThis study will use a special headband that reads brain waves to see how adults with mild to moderate atopic dermatitis (eczema) respond to a single application of a marketed cream compared to plain water. Twenty participants will have their brain activity measured for signals re…
Phase: NA • Sponsor: NovoBliss Research Pvt Ltd • Aim: Knowledge-focused
Last updated Aug 07, 2026 00:00 UTC
-
Scientists track severe allergies to uncover hidden patterns
Knowledge-focused CompletedThis completed study followed 945 people, mostly children and young adults with severe eczema or related allergic conditions, along with their relatives. Researchers observed how these diseases progress over up to a year, using tests like allergy skin pricks, blood draws, and lun…
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Aug 06, 2026 00:00 UTC
-
Could a common wound dressing trigger allergic skin reactions?
Knowledge-focused CompletedThis study looks at whether Aquacel, a silver-containing wound dressing used after hip or knee replacement surgery, can cause allergic contact dermatitis—a type of skin rash. Researchers will compare patients having their first joint replacement with those who had a previous join…
Phase: PHASE4 • Sponsor: Rush University Medical Center • Aim: Knowledge-focused
Last updated Aug 06, 2026 00:00 UTC
-
Can repeated weight loss and gain harm Athletes' metabolism?
Knowledge-focused CompletedThis study looks at how athletes who regularly lose and regain weight to meet competition categories experience changes in metabolism, body temperature, and body composition. Researchers will track 48 athletes through periods of weight maintenance, loss, and regain, using body te…
Phase: NA • Sponsor: University Hospital, Clermont-Ferrand • Aim: Knowledge-focused
Last updated Aug 05, 2026 00:00 UTC
-
Time-Restricted eating shows promise for psoriasis inflammation
Knowledge-focused CompletedThis pilot study tested whether time-restricted feeding (eating all daily calories between 8am and 2pm, then fasting for 18 hours) could reduce inflammation in men with mild to moderate psoriasis. 27 participants (including healthy volunteers) stayed at the clinic for 4.5 days, w…
Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Knowledge-focused
Last updated Aug 02, 2026 00:00 UTC
-
Shingles in cancer patients: a hidden cost burden?
Knowledge-focused CompletedThis study looks back at medical records of 150 adults with active cancer who had a confirmed case of shingles (herpes zoster). The goal is to understand the clinical features of shingles in these patients, such as how it spreads and complications like long-term nerve pain, and t…
Sponsor: AC Camargo Cancer Center • Aim: Knowledge-focused
Last updated Aug 02, 2026 00:00 UTC
-
Do future doctors know the skin risks of tattoos and piercings?
Knowledge-focused CompletedThis study surveys medical students to understand their attitudes toward tattoos and piercings and measure their awareness of related skin risks, such as infections, allergic reactions, and scarring. Researchers aim to see if students have adequate knowledge and how their views d…
Sponsor: Biruni University • Aim: Knowledge-focused
Last updated Jul 30, 2026 00:00 UTC
-
A closer look at the scalp: could trichoscopy predict fungal cure?
Knowledge-focused CompletedThis observational study in children and adolescents with tinea capitis (a scalp fungal infection) investigates whether changes seen under a trichoscope—a special microscope for hair and scalp—can predict when the infection is cured. Participants receive the antifungal drug terbi…
Sponsor: Istanbul Medeniyet University • Aim: Knowledge-focused
Last updated Jul 30, 2026 00:00 UTC
-
What drives eyelid cancer in eastern morocco? a new study digs into the data
Knowledge-focused CompletedThis study reviews the medical records of 20 people treated for eyelid carcinomas at a hospital in eastern Morocco. Researchers are examining patient characteristics, tumor types, and surgical approaches to better understand how these cancers present and are managed in this regio…
Sponsor: Mohammed VI University Hospital • Aim: Knowledge-focused
Last updated Jul 25, 2026 00:00 UTC
-
Can a tiny camera improve ear surgery? a decade of data puts endoscopic techniques to the test
Knowledge-focused CompletedThis study looks back at 12 years of cholesteatoma surgeries at a French hospital to see how the shift to exclusive endoscopic ear surgery (EES) has affected outcomes. Researchers are comparing rates of residual disease, recurrence, and hearing improvement between patients treate…
Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Knowledge-focused
Last updated Jul 25, 2026 00:00 UTC
-
Home hospital care for infections: when does it fail?
Knowledge-focused CompletedThis study looks back at medical records of adults who were sent home from the emergency department to receive hospital-level care for common infections like pneumonia, urinary tract infections, or skin infections. The goal is to understand why some of these patients end up needi…
Sponsor: Chimei Medical Center • Aim: Knowledge-focused
Last updated Jul 24, 2026 00:00 UTC
-
Psoriasis Patients' quality of life under the microscope
Knowledge-focused CompletedThis study looks at the features of psoriasis and how the skin condition impacts the quality of life of patients visiting Tanta University Hospitals. Researchers will collect information from 170 adults with psoriasis to understand the disease's effects on their daily lives. The …
Sponsor: Tanta University • Aim: Knowledge-focused
Last updated Jul 18, 2026 00:00 UTC
-
Scientists hunt for biological clues to severe childhood eczema
Knowledge-focused CompletedThis study looks at children with eczema (atopic dermatitis) that is not well controlled by prescription creams or for whom such creams are not advised. Researchers are collecting blood and cheek swab samples to find biological markers (biomarkers) that may be linked to how the d…
Sponsor: Sanofi • Aim: Knowledge-focused
Last updated Jul 08, 2026 00:00 UTC
-
Hospital skin consultations reveal hidden patterns
Knowledge-focused CompletedThis study looks back at over 300 dermatology consultations requested by non-skin doctors in a university hospital over two and a half years. The goal is to understand what kinds of skin conditions are most common, such as infections, rashes, drug reactions, or tumors. By identif…
Sponsor: Biruni University • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
What makes skin cancer patients happy after surgery?
Knowledge-focused CompletedThis study looks at how satisfied people are after having skin cancer surgery. Researchers ask patients to rate their experience with the surgeon, the facility, the procedure itself, and their recovery. The goal is to understand what matters most to patients and find ways to impr…
Sponsor: Northwestern University • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
Acne Drug's hidden toll on the eye revealed
Knowledge-focused CompletedThis study looks at how isotretinoin, a vitamin A-based acne medication, affects eye structures and tear production in people with severe cystic acne. Participants receive standard treatment and undergo eye exams, including dry eye tests and advanced imaging, before and during th…
Phase: NA • Sponsor: Demet Mutlu • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
Past gum disease may impact Long-Term dental implant success
Knowledge-focused CompletedThis study followed 55 people with dental implants for 5 years to see if their history of gum disease (aggressive, chronic, or none) affected implant health. Participants received regular dental cleanings. Researchers measured bone loss, gum inflammation, and implant survival. Th…
Sponsor: University of Campinas, Brazil • Aim: Knowledge-focused
Last updated Jun 28, 2026 00:00 UTC
-
AI reads social media posts to spot suicide risk in skin cancer patients
Knowledge-focused CompletedThis study enrolled 500 skin cancer patients in China and analyzed over 1.2 million of their social media posts using artificial intelligence. The goal was to see if AI could detect signs of psychological distress and suicidal thoughts. Researchers hope this approach could lead t…
Sponsor: West China Hospital • Aim: Knowledge-focused
Last updated Jun 28, 2026 00:00 UTC
-
Real-World study tracks Poteligeo's impact on rare skin cancer symptoms
Knowledge-focused CompletedThis completed observational study followed 73 adults with mycosis fungoides or Sézary syndrome who were starting treatment with Poteligeo. Researchers tracked changes in symptoms like itching, skin pain, and fatigue, as well as quality of life for patients and their caregivers. …
Sponsor: Kyowa Kirin Pharmaceutical Development Ltd • Aim: Knowledge-focused
Last updated Jun 28, 2026 00:00 UTC
-
Psoriasis Drug's skin gene secrets revealed in small trial
Knowledge-focused CompletedThis study looked at how the drug adalimumab affects gene activity in the skin of people with chronic plaque psoriasis. Researchers compared skin samples from normal, non-lesional, and lesional areas before and after treatment. The goal was to understand the immune changes that h…
Phase: PHASE2 • Sponsor: Poitiers University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:03 UTC
-
Scientists map metabolic shifts in skin cancer development
Knowledge-focused CompletedThis study examined 119 people with precancerous or early skin cancer lesions to understand how cells change as they become cancerous. Researchers took small skin samples and analyzed their metabolism and protein markers. The goal was to learn more about the transition from harml…
Phase: NA • Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
Jump start: simple Warm-Up trick may improve speed and stability
Knowledge-focused CompletedThis study looked at whether doing drop jumps during warm-up helps young basketball players jump higher, sprint faster, and land more stably. Twenty-two athletes were split into two groups: one added drop jumps to their warm-up for 8 weeks, the other did not. Researchers measured…
Phase: NA • Sponsor: University of Palermo • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
Can a short training help caregivers prevent bedsores?
Knowledge-focused CompletedThis study tested whether a face-to-face training session on pressure ulcer prevention improves the knowledge of caregivers of palliative care patients. 70 caregivers participated, and their knowledge was measured before and after training. The goal was to see if this simple educ…
Phase: NA • Sponsor: Abant Izzet Baysal University • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
Pedal power: strength training boosts cyclist performance, but gains fade
Knowledge-focused CompletedThis study looked at whether adding strength training to regular cycling workouts helps competitive cyclists improve performance and muscle function. Twenty-four male cyclists either did strength training plus endurance training or just endurance training for 10 weeks. Researcher…
Phase: NA • Sponsor: Lithuanian Sports University • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Hunting for hidden genes behind albinism
Knowledge-focused CompletedThis study investigates people with oculocutaneous albinism who have no known genetic cause for their condition. Researchers use advanced DNA analysis techniques to search for new or hidden mutations. The goal is to improve diagnosis and understanding of this inherited condition.
Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
AI listens in to free up Doctors' time
Knowledge-focused CompletedThis study tested an AI voice assistant that listens to conversations between neurologists and patients, then automatically fills out electronic medical records. Researchers timed 320 visits with and without the AI to see if it saved doctors time and improved patient care. The go…
Phase: NA • Sponsor: Research and Practical Clinical Center for Diagnostics and Telemedicine Technologies of the Moscow Health Care Department • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Study aims to unlock secrets of immunotherapy skin reactions
Knowledge-focused CompletedThis study observed 255 cancer patients receiving immunotherapy to understand why some develop skin side effects. Researchers measured immune markers and lipids in the skin and blood. The goal is to identify patterns that could predict or explain these reactions.
Sponsor: National Jewish Health • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Small study compares recovery after two chest surgery methods
Knowledge-focused CompletedThis study looked at how patients recover right after two different types of chest surgery: open surgery (thoracotomy) and keyhole surgery (VATS). Researchers measured fear of movement, pain, breathing difficulty, fatigue, and anxiety in 18 adults before they left the hospital. T…
Sponsor: Hacettepe University • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
AI writes acne guide, students score same as human version
Knowledge-focused CompletedThis study tested whether AI-generated educational material on acne could teach medical students as well as standard human-written material. 190 first- and second-year medical students were split into three groups: one read AI-generated content, one read content from the Turkish …
Phase: NA • Sponsor: Hasan Durmuş • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
New protein clue may help track Behcet's disease activity
Knowledge-focused CompletedThis study looked at a protein called FSTL-1 in the blood of 80 adults with Behcet's disease. The goal was to see if higher or lower levels of this protein are linked to how active the disease is. No treatments were tested; the study only measured and compared protein levels with…
Sponsor: Assiut University • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Could your phone be harming your skin? new study investigates screen time and skin disease
Knowledge-focused CompletedThis study measures how much time adults spend on screens (smartphones, computers, tablets, and TV) and checks if higher screen time is linked to specific skin conditions. Researchers will compare screen time across different dermatological diagnoses in patients visiting a dermat…
Sponsor: Biruni University • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:07 UTC
-
Scleroderma Patients' nutrition under the microscope
Knowledge-focused CompletedThis study followed 150 adults with systemic sclerosis (scleroderma) for two years to track their nutritional health. Researchers measured weight, diet, and disease severity every six months. If malnutrition was found, patients received dietary advice or supplements. The goal was…
Sponsor: University Hospital, Montpellier • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:07 UTC
-
Ultrasound peers at blood vessels in scleroderma patients
Knowledge-focused CompletedThis study used color Doppler ultrasound to look at blood vessels in the belly and hands of 30 adults with systemic sclerosis (scleroderma). The goal was to see how the disease affects larger blood vessels. Participants had an ultrasound scan of arteries in the abdomen and wrist.…
Sponsor: Assiut University • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:07 UTC
-
Study reveals bone risks from common skin treatment
Knowledge-focused CompletedThis study looked at 47 people with bullous pemphigoid, a blistering skin condition, who were treated with high-dose topical corticosteroids (clobetasol propionate) for 6 months. Researchers measured bone mineral density at the start, at 3 months, and at 6 months to see if the tr…
Phase: PHASE4 • Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:07 UTC
-
Could a common virus be behind rashes in blood cancer patients?
Knowledge-focused CompletedThis study looked for a virus called HHV6 in the skin and blood of 37 adults with blood cancers who developed a rash during hospital stays. The goal was to see if the virus is linked to the rash, which could help doctors diagnose and treat the rash more effectively. The study is …
Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:06 UTC
-
New study tests if food changes how a skin drug works
Knowledge-focused CompletedThis study looks at how taking VC005 tablets with or without food changes the drug's levels in the blood. It involves 30 healthy adults aged 18 to 45. The goal is to gather information to help design future studies for atopic dermatitis (eczema). Participants will take the drug t…
Phase: PHASE1 • Sponsor: Jiangsu vcare pharmaceutical technology co., LTD • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:05 UTC
-
French study maps scalp ringworm fungi and drug resistance
Knowledge-focused CompletedThis completed study looked at scalp ringworm, a common fungal infection in children, across 11 French centers in 2023. Researchers collected 701 fungal samples to identify the species and test their sensitivity to common antifungal drugs. The goal was to understand which fungi c…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:04 UTC
-
Snap and measure: new photo method tracks nose shape after skin cancer surgery
Knowledge-focused CompletedThis study tested a simple photo-based method to measure changes in nose shape and size after skin cancer surgery. Researchers took before-and-after photos of 68 patients who had surgery for common skin cancers. The goal was to see if this photographic approach could be a reliabl…
Sponsor: NHS Grampian • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:04 UTC
-
Are women with autoimmune diseases getting the gynecological care they need?
Knowledge-focused CompletedThis study examined whether women with autoimmune diseases or inflammatory rheumatism receive proper gynecological follow-up, including cervical cancer screening and contraception advice. Researchers surveyed 318 women with conditions like lupus, rheumatoid arthritis, and Sjögren…
Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:03 UTC
-
Real-world nivolumab use in melanoma: what happens after surgery?
Knowledge-focused CompletedThis study watched 152 melanoma patients who had their tumors surgically removed and then started nivolumab as part of their normal care. Researchers tracked how long patients stayed cancer-free, whether the cancer spread, and overall survival. The goal was to see how well the dr…
Sponsor: Bristol-Myers Squibb • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:01 UTC
-
Rare fat disorder gene hunt: just 2 patients could unlock answers
Knowledge-focused CompletedThis study looked for a new gene that causes hereditary lipodystrophy, a rare disease where people lose body fat and often develop diabetes and heart problems. Researchers studied DNA and cells from 2 patients who had the disease but no known genetic cause. The goal was to find t…
Phase: NA • Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
Study reveals vaccine response in Immune-Compromised patients
Knowledge-focused CompletedThis study looked at how people with autoimmune diseases like multiple sclerosis or blistering skin conditions respond to COVID-19 vaccines while on B-cell depleting therapies. Researchers measured antibody levels and T-cell activity over time to understand vaccine effectiveness …
Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:38 UTC
-
Fizzy science: do prebiotic sodas beat regular soda on hunger and blood sugar?
Knowledge-focused CompletedThis study looked at how four different drinks—two prebiotic sodas, regular Coca-Cola, and Diet Coke—affect hunger, blood sugar, insulin, and appetite hormones in healthy men aged 18-40. Ten participants visited the lab four times, each time drinking one of the beverages in a ran…
Phase: NA • Sponsor: Texas Christian University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
New study aims to predict painful skin rash in hospital patients
Knowledge-focused CompletedThis study looked at 271 hospital patients with incontinence to find out which factors most strongly predict a common skin problem called incontinence-associated dermatitis (IAD). Researchers tracked things like age, stool consistency, and mobility, checking patients' skin daily.…
Sponsor: Örebro University, Sweden • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
Scientists uncover immune cell clues in rare scleroderma
Knowledge-focused CompletedThis study looked at 235 people to understand how certain immune cells, called innate T cells, might be involved in systemic sclerosis (a rare disease that causes hardening of the skin and organs). Researchers compared patients with systemic sclerosis to those with other autoimmu…
Phase: NA • Sponsor: Poitiers University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
Melanoma enzyme study could unlock secrets of treatment resistance
Knowledge-focused CompletedThis completed study examined 127 melanoma patients to understand how the IL4I1 enzyme influences disease progression and resistance to treatments like immunotherapy and targeted therapy. Researchers analyzed blood and tumor tissue samples before and after treatment. The goal was…
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:35 UTC
-
Blood drug levels may predict side effects in skin cancer treatment
Knowledge-focused CompletedThis study looked at 27 people with advanced basal cell skin cancer who were taking the drug vismodegib. The goal was to see if the amount of drug in their blood was linked to side effects like muscle cramps, hair loss, and taste changes. Researchers monitored patients for 6 mont…
Phase: PHASE4 • Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:35 UTC
-
Scientists probe Fat-Immune link in rare and common metabolic diseases
Knowledge-focused CompletedThis completed study looked at 126 people with different fat distribution patterns—including those with lipodystrophy (abnormal fat loss or distribution), obesity, and normal weight—to understand how fat tissue relates to insulin resistance and immune signals. Researchers measure…
Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:34 UTC
-
Tiny particles may hold clues to autoimmune diseases
Knowledge-focused CompletedThis study looked at tiny particles called microparticles in the blood and urine of people with lupus or scleroderma. Researchers wanted to see if these particles could help explain how these diseases work and possibly lead to better diagnosis or treatment. Over 200 adults partic…
Phase: NA • Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:34 UTC
-
Tummy tuck upgrade? liposuction combo found safe in small trial
Knowledge-focused CompletedThis study looked at whether it's safe to do liposuction at the same time as a tummy tuck (abdominoplasty). 63 adults were split into groups that had different amounts of skin lifting with or without liposuction. The goal was to see if the combination caused more complications li…
Phase: NA • Sponsor: Cairo University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:33 UTC
-
Oxygen therapy may give athletes an edge
Knowledge-focused CompletedThis study tested whether 40 sessions of hyperbaric oxygen therapy (breathing pure oxygen in a pressurized chamber) could improve aerobic and anaerobic fitness in healthy athletes. 59 participants, aged 18-25 or 40-50, underwent either real or sham treatment over two months. Rese…
Phase: NA • Sponsor: Assaf-Harofeh Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:33 UTC
-
Gene-Guided surgery may boost healing of stubborn leg wounds
Knowledge-focused CompletedThis study tested whether using genetic information to guide surgical cleaning (debridement) could improve healing in people with hard-to-heal venous leg ulcers. Researchers analyzed genes and proteins from wound samples before and after the procedure. The goal was to see if this…
Phase: NA • Sponsor: University of Miami • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:33 UTC
-
Hidden danger: blood clot prevention device may cause pressure sores
Knowledge-focused CompletedThis completed study from Israel examined 4,500 ICU patients to see if intermittent pneumatic compression (IPC) devices, which are used to prevent dangerous blood clots, might also cause pressure sores. The researchers focused on sores around the ankles and other bony areas. The …
Sponsor: Assuta Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC
-
Scientists probe Immune-Vessel link in rare scleroderma
Knowledge-focused CompletedThis study looked at how blood vessel cells and immune cells talk to each other in people with systemic sclerosis, a rare autoimmune disease that causes skin hardening and organ damage. Researchers collected blood samples and skin biopsies from 350 participants to measure a speci…
Phase: NA • Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC
-
New moisturizer study seeks to understand eczema patients on strong medications
Knowledge-focused CompletedThis study looked at how adults with moderate-to-severe atopic dermatitis (eczema) that is controlled by systemic treatments (like pills or injections) use and feel about a cosmetic moisturizer called RV4427C WM0071. The goal was to understand their needs, expectations, and how s…
Sponsor: Pierre Fabre Dermo Cosmetique • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC
-
Scientists probe immune Cells' role in scleroderma blood vessel injury
Knowledge-focused CompletedThis completed study looked at how certain immune cells (T cells and NK cells) might damage blood vessels in people with systemic sclerosis, a rare autoimmune disease. Researchers analyzed blood samples from 30 participants to measure a protein called Fractalkine and study cell i…
Phase: NA • Sponsor: Assistance Publique Hopitaux De Marseille • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:31 UTC
-
New scale could help prevent bedsores in intensive care
Knowledge-focused CompletedThis study tested whether a Spanish pressure injury risk scale, called EVARUCI, works well in Turkish intensive care units. Researchers translated it and checked its accuracy in 100 adult ICU patients without existing bedsores. The goal was to give nurses a reliable way to spot p…
Sponsor: Istanbul University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:31 UTC
-
Food safety training put to the test: do workers learn better habits?
Knowledge-focused CompletedThis study looked at whether a food safety training program helps food service employees improve their knowledge, attitudes, and practices around safe food handling. About 200 adult workers took part, and the training covered personal hygiene and safe food preparation. The goal w…
Phase: NA • Sponsor: Kayseri University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:30 UTC
-
Study reveals hidden toll of skin changes in rare disease
Knowledge-focused CompletedThis study looked at how skin changes from systemic sclerosis affect a person's feelings about their appearance. Researchers compared 170 patients with the disease to healthy people using surveys about body image and emotional distress. The goal was to understand the burden of th…
Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
Moisturizer habits of eczema patients under systemic therapy revealed
Knowledge-focused CompletedThis study looked at 80 adults with moderate-to-severe atopic dermatitis (eczema) whose condition is controlled by systemic treatments. Researchers wanted to understand how these patients use moisturizers and what they expect from them. Participants filled out questionnaires abou…
Sponsor: Pierre Fabre Dermo Cosmetique • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
Can training ease the burden of caring for fragile skin? new study investigates.
Knowledge-focused CompletedThis study looked at whether specialized training for nurses on how to care for children with a rare, severe skin condition called epidermolysis bullosa (EB) can reduce their stress and anxiety. The study involved 19 nurses and nursing assistants at a hospital in France. Research…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
Lichen planus may mess with your sense of smell and taste, study finds
Knowledge-focused CompletedThis completed study looked at whether lichen planus, a chronic inflammatory condition, affects smell and taste. 88 adults (patients and healthy controls) took smell and taste tests and had oral and nasal exams. The goal was to see if mucosal involvement is linked to sensory chan…
Sponsor: Istanbul Training and Research Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
Escape room boosts nursing Students' pressure ulcer knowledge
Knowledge-focused CompletedThis study tested whether playing an escape room game helps nursing students learn about pressure ulcers (bedsores) better than just listening to a lecture. 51 senior nursing students took part. The game group showed improved knowledge right after and one month later compared to …
Phase: NA • Sponsor: Aydin Adnan Menderes University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:28 UTC
-
Eczema drug Tralokinumab's eye risks under the microscope
Knowledge-focused CompletedThis study looked at 100 adults with atopic dermatitis (eczema) who were prescribed tralokinumab. Researchers tracked how many developed eye problems like conjunctivitis within 4 months of starting the drug. The goal was to better understand these side effects in real-world use, …
Sponsor: Nantes University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:28 UTC
-
App vs. phone: which triage method guides patients better?
Knowledge-focused CompletedThis study tested whether a digital symptom checker could work as well as a traditional phone call for guiding patients to the right level of care. Researchers planned to include 120 adults from a primary care center, but only 22 took part. The main goal was to see if a larger tr…
Phase: NA • Sponsor: Region Skane • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:28 UTC
-
Super shoes under scrutiny: do they lead to more injuries?
Knowledge-focused CompletedThis study looked at 134 competitive runners to see if advanced footwear technology (AFT) — the springy, carbon-fiber shoes many elite athletes wear — is linked to more muscle and tendon injuries. Researchers surveyed athletes about their training habits and injury history over t…
Sponsor: University of Oviedo • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:28 UTC
-
Hockey hand injuries under the microscope: new study aims to protect players
Knowledge-focused CompletedThis completed study looked at hand and wrist injuries in professional hockey players in the Swedish Hockey League over three seasons. Researchers analyzed injury data from about 2,300 games to understand what types of injuries happen, when they occur, and which players are most …
Sponsor: Dalarna County Council, Sweden • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:25 UTC
-
New training boosts Nurses' skills to prevent bedside device injuries
Knowledge-focused CompletedThis study tested a training program for 30 intensive care nurses to improve their knowledge and care for medical device-related pressure injuries (like sores from tubes or masks). Nurses learned through a structured program and were tested before, right after, and one month late…
Phase: NA • Sponsor: University of Gaziantep • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:25 UTC
-
Can a Nurse-Led program help psoriasis patients take control?
Knowledge-focused CompletedThis pilot study tested a nurse-led educational program for people with psoriasis. Twenty-four participants received extra education sessions over six weeks, alongside standard care. The goal was to see if the program was feasible and could improve disease knowledge, self-managem…
Phase: NA • Sponsor: School of Health Sciences Geneva • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:24 UTC
-
HAE patients and caregivers speak out: the hidden costs of On-Demand treatment
Knowledge-focused CompletedThis completed French survey of 300 hereditary angioedema (HAE) patients and their caregivers aimed to understand the challenges of using on-demand treatments for HAE attacks. Researchers collected data on attack frequency, severity, treatment delays, hospitalizations, and the fi…
Sponsor: University Hospital, Grenoble • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:24 UTC
-
Childhood radiation for benign tumors may affect adult brain function
Knowledge-focused CompletedThis study looks at adults who received low-dose radiation to the brain as children for a non-cancerous skin growth. Researchers want to see if this radiation caused any long-term thinking or memory problems. About 150 participants will take memory and thinking tests to compare t…
Phase: NA • Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Which lung test is best for scleroderma patients?
Knowledge-focused CompletedThis study compared two commercially available devices that measure how well the lungs transfer nitric oxide and carbon monoxide. Nine adults with systemic sclerosis and related lung disease took part. Each person was tested with both devices in random order to see if the results…
Sponsor: Holger Dressel • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
UK study seeks best way to spot leg ulcers early
Knowledge-focused CompletedThis study looked at how doctors in the UK currently diagnose and manage venous leg ulcers. Researchers surveyed 135 primary care doctors and vascular specialists to understand current practices and what guidelines are needed. The goal is to find the most effective and cost-effic…
Sponsor: Imperial College London • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:07 UTC
-
Cuddle cure: skin contact after C-Section boosts breastfeeding and calms nerves
Knowledge-focused CompletedThis study tested whether holding a newborn skin-to-skin right after a C-section (within 5 minutes) or within the first hour helps with breastfeeding, reduces anxiety, and keeps mom and baby healthy. 92 mothers and their newborns took part. The results showed that early contact c…
Phase: NA • Sponsor: Çankırı Karatekin University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:07 UTC
-
Can a simple blood test predict immunotherapy results for melanoma patients?
Knowledge-focused CompletedThis study involved 60 people with advanced melanoma who were already scheduled to receive immunotherapy drugs. Researchers collected blood samples and, when possible, tumor samples before and during treatment to look for biological markers that might predict whether the treatmen…
Phase: NA • Sponsor: Institut Claudius Regaud • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:07 UTC
-
Virtual skin checks may save patients from unnecessary hospital stays
Knowledge-focused CompletedThis study looked at whether having a dermatologist review a patient's skin condition remotely (teledermatology) could help emergency room doctors correctly identify true cellulitis (a bacterial skin infection) versus pseudocellulitis (a condition that looks like cellulitis but i…
Phase: NA • Sponsor: Ohio State University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:04 UTC
-
Scientists investigate protein link in skin diseases
Knowledge-focused CompletedThis study looked at skin samples from 170 people with psoriasis, atopic dermatitis (eczema), or healthy skin to understand how a protein called Lyn is involved in inflammation. Researchers measured Lyn activity and related enzymes in both affected and unaffected skin. The goal w…
Phase: NA • Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:02 UTC
-
COVID-19's hidden toll on autoimmune patients revealed
Knowledge-focused CompletedThis study followed 293 people with autoimmune diseases and healthy volunteers to see how COVID-19 infection or vaccination affects their immune system, inflammation, and blood vessels. Participants were grouped based on their COVID-19 history and had up to 5 visits over 12-18 mo…
Sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC
-
Can we shorten antibiotic treatment for cellulitis? new study seeks answers
Knowledge-focused CompletedCellulitis is a painful skin infection that often requires antibiotics, but the ideal treatment length is unknown. This study followed 230 adults hospitalized with cellulitis to identify factors that predict a good recovery, such as medical history and early response to treatment…
Sponsor: University of Sussex • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC
-
Scleroderma hand study reveals key differences in disability
Knowledge-focused CompletedThis study looked at 30 adults with scleroderma, an autoimmune disease that often causes hand stiffness and disability. Researchers measured how much movement was limited in each hand to compare the dominant and non-dominant sides. The goal was to better understand hand function …
Phase: NA • Sponsor: University Hospital, Limoges • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC
-
How many autoimmune patients try alternative therapies? new study counts
Knowledge-focused CompletedThis completed study surveyed 121 adults with autoimmune diseases like lupus, Sjögren's syndrome, or scleroderma. Participants filled out a questionnaire about their use of alternative medicines. The goal was to find out how common these practices are in this patient group.
Sponsor: University Hospital, Limoges • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC
-
Psoriasis patients' satisfaction with biologics: it's not just about skin clearance
Knowledge-focused CompletedThis completed study looked at 52 adults with plaque psoriasis who had been on biologic drugs for at least one year. Researchers used questionnaires to measure treatment satisfaction, quality of life, depression, and personality type. The goal was to find out which clinical and p…
Sponsor: Catholic University of the Sacred Heart • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC
-
Could a common virus fuel painful mouth disease?
Knowledge-focused CompletedThis study explored whether the Epstein-Barr virus (EBV) contributes to inflammation in oral lichen planus, a chronic mouth condition that can be painful. Researchers measured levels of EBV genetic material in 13 adults with the atrophic or erosive form of the disease. The goal w…
Phase: NA • Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC
-
New tool aims to better measure psoriasis burden over a lifetime
Knowledge-focused CompletedThis study tested a new questionnaire called DermCLCI-p to see if it accurately measures the long-term life impacts of moderate-to-severe psoriasis. 154 adults starting the medication risankizumab filled out the 30-question survey over 28 weeks. The goal was to validate the tool …
Sponsor: AbbVie • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC
-
Tiny study hopes to simplify muscle testing for rare muscle disease
Knowledge-focused CompletedThis study looked at a new way to measure muscle function in people with inflammatory myopathies (diseases that cause muscle weakness). Researchers compared a simple test called the Myositis Functional Index-3 with advanced computerised muscle testing. They also tested whether a …
Phase: NA • Sponsor: Federal University of Espirito Santo • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC
-
Could a seed protein stop oral cancer? early study hints at promise
Knowledge-focused CompletedThis early-phase study looked at whether a protein from the Maackia amurensis seed (MASL) can target a receptor called podoplanin found on oral cancer and precancerous cells. Researchers measured how much of this receptor was present in tissue samples from 18 adults with suspicio…
Phase: EARLY_PHASE1 • Sponsor: Rowan University • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:03 UTC
-
Eyelid Surgery's Long-Term effects on dark circles revealed
Knowledge-focused CompletedThis study looked back at 120 people who had lower eyelid surgery to remove bags. Researchers wanted to see how the surgery affected dark circles and wrinkles around the eyes months to years later. They used photos and rating scales to measure changes in skin color and wrinkle se…
Sponsor: Peking Union Medical College • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:02 UTC
-
Skin cancer drug sonidegib under safety watch in Real-World study
Knowledge-focused CompletedThis completed study looked at the long-term safety of the drug sonidegib in 323 adults with a type of skin cancer called locally advanced basal cell carcinoma. Participants took a daily 200 mg pill, and researchers tracked side effects, serious events, and deaths. The goal was t…
Sponsor: Sun Pharmaceutical Industries Limited • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:02 UTC
-
Heart transplant warning: could a simple virus test spot rejection early?
Knowledge-focused CompletedThis study followed 60 heart transplant patients for one year to see if levels of a harmless virus called TTV in the blood are linked to infections or organ rejection. Researchers took monthly blood samples alongside routine care. The goal is to find a new way to monitor transpla…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:01 UTC
-
Genetic sleuths hunt for hidden causes of rare skin disorder
Knowledge-focused CompletedThis study used advanced genetic sequencing to find new genes responsible for syndromic poikiloderma, a rare condition affecting skin and other organs. Researchers analyzed DNA from 39 patients to improve diagnosis, genetic counseling, and tumor risk monitoring. The goal is to he…
Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:01 UTC
-
Eczema mystery: could skin fungi be the culprit on your face and neck?
Knowledge-focused CompletedThis study looked at the types of fungi living on the head and neck skin of 30 adults with eczema (atopic dermatitis) compared to healthy volunteers. The goal was to understand if differences in the fungal community are linked to eczema in these areas. Researchers used advanced l…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:00 UTC
-
Dupilumab in pregnancy: no major safety signals found
Knowledge-focused CompletedThis study looked at whether the drug dupilumab, used for eczema or asthma, is safe during pregnancy. Researchers compared 581 pregnant women who took dupilumab with those who did not. They tracked birth defects, miscarriages, and infant health up to one year old to see if the dr…
Sponsor: Regeneron Pharmaceuticals • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:11 UTC
-
Scientists investigate why skin fails to heal in rare blistering disease
Knowledge-focused CompletedThis study looked at how skin cells from 30 people with recessive dystrophic epidermolysis bullosa (RDEB) grow and repair wounds. RDEB is a rare genetic condition that causes fragile skin and painful blisters. Researchers took small skin samples to study the cells in a lab, aimin…
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:09 UTC